Correlation between copy number variation genes (focal events) and selected clinical features
Pan-kidney cohort (KICH+KIRC+KIRP) (Primary solid tumor)
02 April 2015  |  analyses__2015_04_02
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2015): Correlation between copy number variation genes (focal events) and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C12B8X27
Overview
Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 39 focal events and 13 clinical features across 859 patients, 253 significant findings detected with Q value < 0.25.

  • amp_1q32.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.

  • amp_2q32.1 cnv correlated to 'PATHOLOGY_N_STAGE' and 'HISTOLOGICAL_TYPE'.

  • amp_3q26.32 cnv correlated to 'YEARS_TO_BIRTH',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_5q35.1 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • amp_7q31.2 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_M_STAGE',  'GENDER',  'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.

  • amp_8q24.22 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'HISTOLOGICAL_TYPE',  'NUMBER_PACK_YEARS_SMOKED', and 'RACE'.

  • amp_10p14 cnv correlated to 'PATHOLOGY_T_STAGE' and 'PATHOLOGY_N_STAGE'.

  • amp_17q25.2 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'GENDER',  'HISTOLOGICAL_TYPE',  'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.

  • amp_19p13.2 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.

  • amp_xp22.2 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'GENDER',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.

  • amp_xp11.4 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'GENDER',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.

  • amp_xq11.2 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'GENDER',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.

  • amp_xq28 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'GENDER',  'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.

  • del_1p36.31 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.

  • del_1p31.1 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'HISTOLOGICAL_TYPE', and 'ETHNICITY'.

  • del_1q43 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.

  • del_2q37.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.

  • del_3p26.3 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'GENDER',  'HISTOLOGICAL_TYPE',  'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.

  • del_3p21.2 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE',  'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.

  • del_3p14.1 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'HISTOLOGICAL_TYPE',  'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.

  • del_3p12.2 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'GENDER',  'HISTOLOGICAL_TYPE',  'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.

  • del_4q34.3 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_5p15.33 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.

  • del_6q22.31 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_6q26 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_6q26 cnv correlated to 'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_8p23.2 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_M_STAGE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_9p23 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_9p21.3 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_10q23.31 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_11q21 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.

  • del_11q23.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.

  • del_13q12.13 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'GENDER',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_13q14.2 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'GENDER',  'HISTOLOGICAL_TYPE', and 'RACE'.

  • del_14q31.1 cnv correlated to 'Time to Death',  'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE',  'HISTOLOGICAL_TYPE',  'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.

  • del_16q23.3 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.

  • del_18q22.2 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'YEAR_OF_TOBACCO_SMOKING_ONSET',  'RACE', and 'ETHNICITY'.

  • del_19p13.3 cnv correlated to 'Time to Death',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE',  'PATHOLOGY_M_STAGE',  'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.

  • del_xp22.2 cnv correlated to 'YEARS_TO_BIRTH',  'NEOPLASM_DISEASESTAGE',  'PATHOLOGY_T_STAGE',  'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 39 focal events and 13 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 253 significant findings detected.

Clinical
Features
Time
to
Death
YEARS
TO
BIRTH
NEOPLASM
DISEASESTAGE
PATHOLOGY
T
STAGE
PATHOLOGY
N
STAGE
PATHOLOGY
M
STAGE
GENDER KARNOFSKY
PERFORMANCE
SCORE
HISTOLOGICAL
TYPE
NUMBER
PACK
YEARS
SMOKED
YEAR
OF
TOBACCO
SMOKING
ONSET
RACE ETHNICITY
nCNV (%) nWild-Type logrank test Wilcoxon-test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Wilcoxon-test Fisher's exact test Wilcoxon-test Wilcoxon-test Fisher's exact test Fisher's exact test
del 14q31 1 274 (32%) 585 8.67e-09
(8.79e-07)
0.0799
(0.178)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.00205
(0.00829)
4.84e-05
(0.000332)
0.699
(0.819)
0.0447
(0.111)
1e-05
(7.57e-05)
0.163
(0.305)
0.00272
(0.0106)
0.011
(0.0346)
1
(1.00)
amp 8q24 22 121 (14%) 738 0.00646
(0.0217)
0.0485
(0.119)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.0615
(0.147)
0.00979
(0.0312)
0.533
(0.664)
0.86
(0.932)
0.00092
(0.0042)
0.118
(0.237)
0.149
(0.287)
0.00454
(0.0162)
1
(1.00)
del 3p21 2 499 (58%) 360 7.97e-06
(7.57e-05)
0.683
(0.803)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.0986
(0.208)
0.0049
(0.017)
0.143
(0.277)
0.0596
(0.143)
1e-05
(7.57e-05)
0.194
(0.342)
0.0343
(0.0893)
1e-05
(7.57e-05)
0.873
(0.936)
del 9p23 196 (23%) 663 2.91e-11
(4.92e-09)
0.0247
(0.068)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.00724
(0.0241)
0.000223
(0.00121)
0.301
(0.453)
0.0204
(0.0586)
1e-05
(7.57e-05)
0.932
(0.966)
0.525
(0.656)
0.0126
(0.0389)
0.704
(0.82)
del 9p21 3 207 (24%) 652 1.12e-14
(5.69e-12)
0.0358
(0.0915)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.00013
(0.000758)
9.23e-06
(7.57e-05)
0.177
(0.323)
0.0401
(0.102)
1e-05
(7.57e-05)
0.932
(0.966)
0.525
(0.656)
0.00827
(0.0271)
0.852
(0.927)
amp 17q25 2 232 (27%) 627 0.592
(0.723)
0.0619
(0.147)
0.00052
(0.00251)
0.003
(0.0114)
0.00017
(0.000968)
0.214
(0.366)
0.000821
(0.00382)
0.514
(0.651)
1e-05
(7.57e-05)
0.987
(1.00)
0.0926
(0.197)
0.0121
(0.0379)
0.228
(0.38)
del 3p26 3 486 (57%) 373 0.00113
(0.00513)
0.786
(0.884)
1e-05
(7.57e-05)
2e-05
(0.000149)
0.00885
(0.0288)
0.133
(0.261)
0.0684
(0.159)
0.151
(0.288)
1e-05
(7.57e-05)
0.43
(0.59)
0.0786
(0.175)
1e-05
(7.57e-05)
0.267
(0.423)
del 11q21 60 (7%) 799 0.00196
(0.0082)
0.00478
(0.0167)
0.00026
(0.00136)
0.00041
(0.00206)
0.00019
(0.00106)
0.0998
(0.209)
0.671
(0.793)
0.0624
(0.147)
0.00304
(0.0114)
0.46
(0.619)
0.886
(0.941)
0.418
(0.578)
0.349
(0.504)
del 11q23 1 70 (8%) 789 0.00373
(0.0136)
0.00293
(0.0112)
3e-05
(0.000214)
1e-05
(7.57e-05)
0.00047
(0.00229)
0.112
(0.228)
0.428
(0.59)
0.0253
(0.0686)
0.00361
(0.0134)
0.669
(0.793)
0.927
(0.965)
0.27
(0.426)
0.242
(0.397)
del 13q12 13 148 (17%) 711 0.0323
(0.0845)
0.000423
(0.0021)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.0135
(0.041)
0.228
(0.38)
0.0212
(0.0604)
0.316
(0.47)
1e-05
(7.57e-05)
0.751
(0.854)
0.278
(0.432)
0.103
(0.213)
0.377
(0.539)
del 13q14 2 148 (17%) 711 0.0241
(0.0666)
8.11e-05
(0.000501)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.015
(0.0449)
0.132
(0.261)
0.0125
(0.0389)
0.379
(0.541)
1e-05
(7.57e-05)
0.914
(0.955)
0.249
(0.407)
0.104
(0.214)
0.66
(0.791)
del 18q22 2 152 (18%) 707 6.48e-07
(5.47e-05)
0.619
(0.749)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.0213
(0.0604)
0.00917
(0.0294)
1
(1.00)
0.56
(0.693)
0.318
(0.472)
0.513
(0.651)
0.117
(0.236)
0.0746
(0.171)
0.0894
(0.192)
amp 1q32 1 81 (9%) 778 0.000273
(0.00141)
0.0313
(0.0827)
3e-05
(0.000214)
0.00019
(0.00106)
0.0705
(0.163)
0.137
(0.269)
0.623
(0.752)
0.297
(0.45)
0.00282
(0.0108)
0.336
(0.491)
0.101
(0.212)
0.149
(0.287)
0.259
(0.415)
amp xq11 2 128 (15%) 731 0.0918
(0.196)
0.468
(0.62)
0.00471
(0.0167)
0.00788
(0.0259)
0.894
(0.945)
0.564
(0.695)
0.000237
(0.00127)
0.0254
(0.0686)
1e-05
(7.57e-05)
0.742
(0.847)
0.0193
(0.0556)
0.184
(0.335)
0.661
(0.791)
del 3p12 2 334 (39%) 525 0.00116
(0.00521)
0.813
(0.902)
0.0127
(0.039)
0.00642
(0.0217)
0.515
(0.651)
0.731
(0.841)
0.0884
(0.191)
0.774
(0.874)
1e-05
(7.57e-05)
0.233
(0.385)
0.0826
(0.182)
0.00473
(0.0167)
0.741
(0.847)
del 4q34 3 111 (13%) 748 7.22e-09
(8.79e-07)
0.671
(0.793)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.0109
(0.0346)
0.0143
(0.043)
0.83
(0.911)
0.885
(0.941)
0.0318
(0.0836)
0.401
(0.561)
0.665
(0.793)
0.0647
(0.151)
0.482
(0.634)
del 6q22 31 225 (26%) 634 0.383
(0.543)
0.124
(0.248)
0.00013
(0.000758)
4e-05
(0.000278)
0.0357
(0.0915)
1
(1.00)
0.681
(0.803)
0.107
(0.219)
1e-05
(7.57e-05)
0.206
(0.356)
0.22
(0.372)
0.00221
(0.00882)
0.263
(0.42)
del 19p13 3 40 (5%) 819 8.5e-12
(2.16e-09)
0.443
(0.601)
6e-05
(0.00038)
1e-05
(7.57e-05)
0.00022
(0.00121)
0.064
(0.15)
0.864
(0.934)
0.0779
(0.175)
0.0287
(0.0763)
0.464
(0.62)
0.334
(0.49)
0.716
(0.829)
amp 3q26 32 185 (22%) 674 0.414
(0.574)
0.116
(0.236)
0.21
(0.361)
0.185
(0.336)
0.0217
(0.061)
0.00735
(0.0244)
0.187
(0.337)
0.107
(0.219)
1e-05
(7.57e-05)
0.38
(0.541)
0.262
(0.419)
0.0571
(0.138)
0.704
(0.82)
amp 5q35 1 372 (43%) 487 0.189
(0.338)
0.129
(0.256)
0.00012
(0.000724)
0.00911
(0.0294)
0.0235
(0.0656)
0.0161
(0.0467)
0.307
(0.459)
0.514
(0.651)
1e-05
(7.57e-05)
0.431
(0.59)
0.274
(0.428)
3e-05
(0.000214)
0.873
(0.936)
amp xp22 2 121 (14%) 738 0.269
(0.425)
0.392
(0.552)
0.0233
(0.0654)
0.0759
(0.173)
0.896
(0.945)
0.252
(0.409)
0.00494
(0.017)
0.0254
(0.0686)
1e-05
(7.57e-05)
0.826
(0.91)
0.044
(0.11)
0.32
(0.474)
0.821
(0.907)
amp xp11 4 129 (15%) 730 0.236
(0.388)
0.28
(0.434)
0.00376
(0.0136)
0.0259
(0.069)
0.897
(0.945)
0.133
(0.261)
0.000532
(0.00254)
0.0254
(0.0686)
1e-05
(7.57e-05)
0.832
(0.911)
0.0579
(0.139)
0.251
(0.408)
0.522
(0.656)
amp xq28 132 (15%) 727 0.0777
(0.175)
0.46
(0.619)
0.0369
(0.094)
0.0412
(0.104)
0.908
(0.953)
0.466
(0.62)
0.016
(0.0465)
0.00192
(0.00811)
1e-05
(7.57e-05)
0.855
(0.928)
0.267
(0.423)
0.162
(0.304)
0.282
(0.435)
del 1p36 31 203 (24%) 656 0.396
(0.556)
0.0774
(0.175)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.0685
(0.159)
0.502
(0.645)
0.496
(0.643)
0.0152
(0.045)
1e-05
(7.57e-05)
0.344
(0.499)
0.327
(0.482)
0.603
(0.732)
0.335
(0.49)
del 1p31 1 161 (19%) 698 0.511
(0.651)
0.0352
(0.091)
4e-05
(0.000278)
5e-05
(0.000334)
0.102
(0.213)
0.885
(0.941)
1
(1.00)
0.229
(0.38)
1e-05
(7.57e-05)
0.473
(0.623)
0.699
(0.819)
0.397
(0.556)
0.0856
(0.186)
del 2q37 3 110 (13%) 749 0.0153
(0.0451)
0.00203
(0.00829)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.282
(0.435)
0.0853
(0.186)
0.516
(0.651)
0.955
(0.986)
1e-05
(7.57e-05)
0.559
(0.692)
0.866
(0.934)
0.494
(0.642)
1
(1.00)
del 3p14 1 405 (47%) 454 0.00206
(0.00829)
0.91
(0.953)
0.00023
(0.00124)
6e-05
(0.00038)
0.219
(0.372)
0.565
(0.695)
0.192
(0.341)
0.286
(0.438)
1e-05
(7.57e-05)
0.34
(0.496)
0.055
(0.133)
0.00013
(0.000758)
0.75
(0.854)
del 6q26 230 (27%) 629 0.302
(0.453)
0.187
(0.337)
6e-05
(0.00038)
5e-05
(0.000334)
0.0548
(0.133)
1
(1.00)
0.624
(0.752)
0.086
(0.186)
1e-05
(7.57e-05)
0.206
(0.356)
0.22
(0.372)
0.00126
(0.0056)
0.191
(0.34)
del 6q26 231 (27%) 628 0.298
(0.45)
0.193
(0.341)
8e-05
(0.000501)
6e-05
(0.00038)
0.0549
(0.133)
1
(1.00)
0.807
(0.899)
0.086
(0.186)
1e-05
(7.57e-05)
0.206
(0.356)
0.22
(0.372)
0.00323
(0.012)
0.192
(0.341)
del 8p23 2 181 (21%) 678 0.000909
(0.00419)
0.501
(0.645)
0.00201
(0.00829)
0.00183
(0.0078)
0.47
(0.62)
0.0257
(0.0689)
0.791
(0.887)
0.434
(0.593)
1e-05
(7.57e-05)
0.491
(0.64)
0.524
(0.656)
0.00376
(0.0136)
0.156
(0.295)
amp 7q31 2 364 (42%) 495 0.91
(0.953)
0.376
(0.539)
0.0134
(0.041)
0.793
(0.887)
0.228
(0.38)
0.00198
(0.00821)
7.63e-06
(7.57e-05)
0.292
(0.445)
1e-05
(7.57e-05)
0.411
(0.571)
0.0146
(0.0439)
0.186
(0.337)
0.259
(0.415)
del 1q43 112 (13%) 747 0.0476
(0.118)
0.00276
(0.0107)
0.00037
(0.00188)
0.00154
(0.00662)
0.275
(0.429)
0.17
(0.314)
0.164
(0.305)
0.139
(0.272)
1e-05
(7.57e-05)
0.831
(0.911)
0.601
(0.731)
0.226
(0.38)
0.146
(0.282)
del 5p15 33 31 (4%) 828 0.948
(0.981)
0.00445
(0.016)
0.00148
(0.00647)
0.00057
(0.0027)
0.00573
(0.0196)
0.741
(0.847)
0.176
(0.323)
0.777
(0.875)
1e-05
(7.57e-05)
0.469
(0.62)
0.253
(0.41)
0.575
(0.706)
0.154
(0.291)
del 10q23 31 162 (19%) 697 0.707
(0.822)
0.0425
(0.107)
1e-05
(7.57e-05)
1e-05
(7.57e-05)
0.341
(0.496)
0.888
(0.941)
0.713
(0.827)
0.283
(0.435)
1e-05
(7.57e-05)
0.214
(0.366)
0.223
(0.375)
0.0994
(0.209)
0.385
(0.544)
del xp22 2 123 (14%) 736 0.918
(0.958)
0.00136
(0.006)
0.0001
(0.000611)
0.00025
(0.00132)
0.0948
(0.201)
0.867
(0.934)
0.538
(0.668)
0.718
(0.829)
1e-05
(7.57e-05)
0.813
(0.902)
0.291
(0.445)
0.152
(0.289)
0.46
(0.619)
amp 19p13 2 97 (11%) 762 0.957
(0.986)
0.436
(0.594)
0.00152
(0.00659)
0.00247
(0.00978)
0.593
(0.723)
0.0156
(0.0456)
0.17
(0.314)
0.301
(0.453)
0.00034
(0.00174)
0.404
(0.563)
0.768
(0.87)
0.507
(0.651)
0.803
(0.897)
del 16q23 3 36 (4%) 823 9.39e-06
(7.57e-05)
0.724
(0.834)
0.00647
(0.0217)
0.00014
(0.000807)
0.00046
(0.00226)
0.353
(0.508)
1
(1.00)
0.489
(0.64)
0.151
(0.288)
0.168
(0.313)
0.82
(0.907)
0.439
(0.596)
1
(1.00)
amp 2q32 1 133 (15%) 726 0.843
(0.921)
0.205
(0.356)
0.257
(0.414)
0.385
(0.544)
0.0752
(0.172)
0.876
(0.937)
0.273
(0.428)
0.467
(0.62)
0.00253
(0.00994)
0.85
(0.927)
0.461
(0.619)
0.491
(0.64)
0.656
(0.788)
amp 10p14 33 (4%) 826 0.67
(0.793)
0.311
(0.463)
0.126
(0.252)
0.00061
(0.00286)
0.0809
(0.179)
0.576
(0.706)
1
(1.00)
0.497
(0.643)
0.514
(0.651)
0.764
(0.866)
0.2
(0.351)
1
(1.00)
'amp_1q32.1' versus 'Time to Death'

P value = 0.000273 (logrank test), Q value = 0.0014

Table S1.  Gene #1: 'amp_1q32.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
AMP PEAK 1(1Q32.1) MUTATED 80 34 0.4 - 94.7 (26.8)
AMP PEAK 1(1Q32.1) WILD-TYPE 763 177 0.1 - 194.8 (30.7)

Figure S1.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #1: 'Time to Death'

'amp_1q32.1' versus 'YEARS_TO_BIRTH'

P value = 0.0313 (Wilcoxon-test), Q value = 0.083

Table S2.  Gene #1: 'amp_1q32.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
AMP PEAK 1(1Q32.1) MUTATED 79 62.5 (12.2)
AMP PEAK 1(1Q32.1) WILD-TYPE 774 59.9 (12.6)

Figure S2.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q32.1' versus 'NEOPLASM_DISEASESTAGE'

P value = 3e-05 (Fisher's exact test), Q value = 0.00021

Table S3.  Gene #1: 'amp_1q32.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 1(1Q32.1) MUTATED 24 10 32 15
AMP PEAK 1(1Q32.1) WILD-TYPE 424 93 158 85

Figure S3.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_1q32.1' versus 'PATHOLOGY_T_STAGE'

P value = 0.00019 (Fisher's exact test), Q value = 0.0011

Table S4.  Gene #1: 'amp_1q32.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 1(1Q32.1) MUTATED 27 12 41 1
AMP PEAK 1(1Q32.1) WILD-TYPE 435 111 210 14

Figure S4.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_1q32.1' versus 'PATHOLOGY_N_STAGE'

P value = 0.0705 (Fisher's exact test), Q value = 0.16

Table S5.  Gene #1: 'amp_1q32.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 1(1Q32.1) MUTATED 35 10 1
AMP PEAK 1(1Q32.1) WILD-TYPE 282 33 5

Figure S5.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_1q32.1' versus 'HISTOLOGICAL_TYPE'

P value = 0.00282 (Fisher's exact test), Q value = 0.011

Table S6.  Gene #1: 'amp_1q32.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 1(1Q32.1) MUTATED 1 62 18
AMP PEAK 1(1Q32.1) WILD-TYPE 65 462 251

Figure S6.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_1q32.1' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.101 (Wilcoxon-test), Q value = 0.21

Table S7.  Gene #1: 'amp_1q32.1' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
AMP PEAK 1(1Q32.1) MUTATED 3 1989.0 (19.2)
AMP PEAK 1(1Q32.1) WILD-TYPE 64 1972.7 (16.1)

Figure S7.  Get High-res Image Gene #1: 'amp_1q32.1' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'amp_2q32.1' versus 'PATHOLOGY_N_STAGE'

P value = 0.0752 (Fisher's exact test), Q value = 0.17

Table S8.  Gene #2: 'amp_2q32.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 2(2Q32.1) MUTATED 47 11 2
AMP PEAK 2(2Q32.1) WILD-TYPE 270 32 4

Figure S8.  Get High-res Image Gene #2: 'amp_2q32.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_2q32.1' versus 'HISTOLOGICAL_TYPE'

P value = 0.00253 (Fisher's exact test), Q value = 0.0099

Table S9.  Gene #2: 'amp_2q32.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 2(2Q32.1) MUTATED 2 80 51
AMP PEAK 2(2Q32.1) WILD-TYPE 64 444 218

Figure S9.  Get High-res Image Gene #2: 'amp_2q32.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_3q26.32' versus 'YEARS_TO_BIRTH'

P value = 0.116 (Wilcoxon-test), Q value = 0.24

Table S10.  Gene #3: 'amp_3q26.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
AMP PEAK 3(3Q26.32) MUTATED 182 61.5 (12.1)
AMP PEAK 3(3Q26.32) WILD-TYPE 671 59.7 (12.7)

Figure S10.  Get High-res Image Gene #3: 'amp_3q26.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.32' versus 'PATHOLOGY_N_STAGE'

P value = 0.0217 (Fisher's exact test), Q value = 0.061

Table S11.  Gene #3: 'amp_3q26.32' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 3(3Q26.32) MUTATED 57 15 0
AMP PEAK 3(3Q26.32) WILD-TYPE 260 28 6

Figure S11.  Get High-res Image Gene #3: 'amp_3q26.32' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_3q26.32' versus 'PATHOLOGY_M_STAGE'

P value = 0.00735 (Fisher's exact test), Q value = 0.024

Table S12.  Gene #3: 'amp_3q26.32' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
AMP PEAK 3(3Q26.32) MUTATED 90 26
AMP PEAK 3(3Q26.32) WILD-TYPE 452 63

Figure S12.  Get High-res Image Gene #3: 'amp_3q26.32' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'amp_3q26.32' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.107 (Wilcoxon-test), Q value = 0.22

Table S13.  Gene #3: 'amp_3q26.32' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
AMP PEAK 3(3Q26.32) MUTATED 31 94.8 (6.8)
AMP PEAK 3(3Q26.32) WILD-TYPE 84 88.6 (19.9)

Figure S13.  Get High-res Image Gene #3: 'amp_3q26.32' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'amp_3q26.32' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S14.  Gene #3: 'amp_3q26.32' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 3(3Q26.32) MUTATED 6 86 93
AMP PEAK 3(3Q26.32) WILD-TYPE 60 438 176

Figure S14.  Get High-res Image Gene #3: 'amp_3q26.32' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_3q26.32' versus 'RACE'

P value = 0.0571 (Fisher's exact test), Q value = 0.14

Table S15.  Gene #3: 'amp_3q26.32' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
AMP PEAK 3(3Q26.32) MUTATED 2 1 24 149
AMP PEAK 3(3Q26.32) WILD-TYPE 0 14 92 553

Figure S15.  Get High-res Image Gene #3: 'amp_3q26.32' versus Clinical Feature #12: 'RACE'

'amp_5q35.1' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00012 (Fisher's exact test), Q value = 0.00072

Table S16.  Gene #4: 'amp_5q35.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 4(5Q35.1) MUTATED 172 42 93 62
AMP PEAK 4(5Q35.1) WILD-TYPE 276 61 97 38

Figure S16.  Get High-res Image Gene #4: 'amp_5q35.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_5q35.1' versus 'PATHOLOGY_T_STAGE'

P value = 0.00911 (Fisher's exact test), Q value = 0.029

Table S17.  Gene #4: 'amp_5q35.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 4(5Q35.1) MUTATED 179 55 130 7
AMP PEAK 4(5Q35.1) WILD-TYPE 283 68 121 8

Figure S17.  Get High-res Image Gene #4: 'amp_5q35.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_5q35.1' versus 'PATHOLOGY_N_STAGE'

P value = 0.0235 (Fisher's exact test), Q value = 0.066

Table S18.  Gene #4: 'amp_5q35.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 4(5Q35.1) MUTATED 161 14 1
AMP PEAK 4(5Q35.1) WILD-TYPE 156 29 5

Figure S18.  Get High-res Image Gene #4: 'amp_5q35.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_5q35.1' versus 'PATHOLOGY_M_STAGE'

P value = 0.0161 (Fisher's exact test), Q value = 0.047

Table S19.  Gene #4: 'amp_5q35.1' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
AMP PEAK 4(5Q35.1) MUTATED 278 58
AMP PEAK 4(5Q35.1) WILD-TYPE 264 31

Figure S19.  Get High-res Image Gene #4: 'amp_5q35.1' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'amp_5q35.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S20.  Gene #4: 'amp_5q35.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 4(5Q35.1) MUTATED 8 330 34
AMP PEAK 4(5Q35.1) WILD-TYPE 58 194 235

Figure S20.  Get High-res Image Gene #4: 'amp_5q35.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_5q35.1' versus 'RACE'

P value = 3e-05 (Fisher's exact test), Q value = 0.00021

Table S21.  Gene #4: 'amp_5q35.1' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
AMP PEAK 4(5Q35.1) MUTATED 0 5 29 331
AMP PEAK 4(5Q35.1) WILD-TYPE 2 10 87 371

Figure S21.  Get High-res Image Gene #4: 'amp_5q35.1' versus Clinical Feature #12: 'RACE'

'amp_7q31.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.0134 (Fisher's exact test), Q value = 0.041

Table S22.  Gene #5: 'amp_7q31.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 5(7Q31.2) MUTATED 193 37 68 54
AMP PEAK 5(7Q31.2) WILD-TYPE 255 66 122 46

Figure S22.  Get High-res Image Gene #5: 'amp_7q31.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_7q31.2' versus 'PATHOLOGY_M_STAGE'

P value = 0.00198 (Fisher's exact test), Q value = 0.0082

Table S23.  Gene #5: 'amp_7q31.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
AMP PEAK 5(7Q31.2) MUTATED 189 47
AMP PEAK 5(7Q31.2) WILD-TYPE 353 42

Figure S23.  Get High-res Image Gene #5: 'amp_7q31.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'amp_7q31.2' versus 'GENDER'

P value = 7.63e-06 (Fisher's exact test), Q value = 7.6e-05

Table S24.  Gene #5: 'amp_7q31.2' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
AMP PEAK 5(7Q31.2) MUTATED 91 273
AMP PEAK 5(7Q31.2) WILD-TYPE 196 299

Figure S24.  Get High-res Image Gene #5: 'amp_7q31.2' versus Clinical Feature #7: 'GENDER'

'amp_7q31.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S25.  Gene #5: 'amp_7q31.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 5(7Q31.2) MUTATED 25 174 165
AMP PEAK 5(7Q31.2) WILD-TYPE 41 350 104

Figure S25.  Get High-res Image Gene #5: 'amp_7q31.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_7q31.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0146 (Wilcoxon-test), Q value = 0.044

Table S26.  Gene #5: 'amp_7q31.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
AMP PEAK 5(7Q31.2) MUTATED 36 1969.0 (15.8)
AMP PEAK 5(7Q31.2) WILD-TYPE 31 1978.5 (15.8)

Figure S26.  Get High-res Image Gene #5: 'amp_7q31.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'amp_8q24.22' versus 'Time to Death'

P value = 0.00646 (logrank test), Q value = 0.022

Table S27.  Gene #6: 'amp_8q24.22' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
AMP PEAK 6(8Q24.22) MUTATED 120 40 0.2 - 152.0 (25.8)
AMP PEAK 6(8Q24.22) WILD-TYPE 723 171 0.1 - 194.8 (31.2)

Figure S27.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.22' versus 'YEARS_TO_BIRTH'

P value = 0.0485 (Wilcoxon-test), Q value = 0.12

Table S28.  Gene #6: 'amp_8q24.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
AMP PEAK 6(8Q24.22) MUTATED 121 62.1 (12.7)
AMP PEAK 6(8Q24.22) WILD-TYPE 732 59.8 (12.5)

Figure S28.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.22' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S29.  Gene #6: 'amp_8q24.22' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 6(8Q24.22) MUTATED 35 22 37 25
AMP PEAK 6(8Q24.22) WILD-TYPE 413 81 153 75

Figure S29.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_8q24.22' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S30.  Gene #6: 'amp_8q24.22' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 6(8Q24.22) MUTATED 36 23 56 4
AMP PEAK 6(8Q24.22) WILD-TYPE 426 100 195 11

Figure S30.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_8q24.22' versus 'PATHOLOGY_N_STAGE'

P value = 0.0615 (Fisher's exact test), Q value = 0.15

Table S31.  Gene #6: 'amp_8q24.22' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 6(8Q24.22) MUTATED 50 12 2
AMP PEAK 6(8Q24.22) WILD-TYPE 267 31 4

Figure S31.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_8q24.22' versus 'PATHOLOGY_M_STAGE'

P value = 0.00979 (Fisher's exact test), Q value = 0.031

Table S32.  Gene #6: 'amp_8q24.22' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
AMP PEAK 6(8Q24.22) MUTATED 73 22
AMP PEAK 6(8Q24.22) WILD-TYPE 469 67

Figure S32.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'amp_8q24.22' versus 'HISTOLOGICAL_TYPE'

P value = 0.00092 (Fisher's exact test), Q value = 0.0042

Table S33.  Gene #6: 'amp_8q24.22' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 6(8Q24.22) MUTATED 18 78 25
AMP PEAK 6(8Q24.22) WILD-TYPE 48 446 244

Figure S33.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_8q24.22' versus 'NUMBER_PACK_YEARS_SMOKED'

P value = 0.118 (Wilcoxon-test), Q value = 0.24

Table S34.  Gene #6: 'amp_8q24.22' versus Clinical Feature #10: 'NUMBER_PACK_YEARS_SMOKED'

nPatients Mean (Std.Dev)
ALL 91 30.8 (26.2)
AMP PEAK 6(8Q24.22) MUTATED 12 20.8 (15.9)
AMP PEAK 6(8Q24.22) WILD-TYPE 79 32.3 (27.2)

Figure S34.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #10: 'NUMBER_PACK_YEARS_SMOKED'

'amp_8q24.22' versus 'RACE'

P value = 0.00454 (Fisher's exact test), Q value = 0.016

Table S35.  Gene #6: 'amp_8q24.22' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
AMP PEAK 6(8Q24.22) MUTATED 0 4 6 108
AMP PEAK 6(8Q24.22) WILD-TYPE 2 11 110 594

Figure S35.  Get High-res Image Gene #6: 'amp_8q24.22' versus Clinical Feature #12: 'RACE'

'amp_10p14' versus 'PATHOLOGY_T_STAGE'

P value = 0.00061 (Fisher's exact test), Q value = 0.0029

Table S36.  Gene #7: 'amp_10p14' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 7(10P14) MUTATED 13 9 7 4
AMP PEAK 7(10P14) WILD-TYPE 449 114 244 11

Figure S36.  Get High-res Image Gene #7: 'amp_10p14' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_10p14' versus 'PATHOLOGY_N_STAGE'

P value = 0.0809 (Fisher's exact test), Q value = 0.18

Table S37.  Gene #7: 'amp_10p14' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 7(10P14) MUTATED 12 5 0
AMP PEAK 7(10P14) WILD-TYPE 305 38 6

Figure S37.  Get High-res Image Gene #7: 'amp_10p14' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_17q25.2' versus 'YEARS_TO_BIRTH'

P value = 0.0619 (Wilcoxon-test), Q value = 0.15

Table S38.  Gene #8: 'amp_17q25.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
AMP PEAK 8(17Q25.2) MUTATED 229 61.4 (12.3)
AMP PEAK 8(17Q25.2) WILD-TYPE 624 59.6 (12.6)

Figure S38.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q25.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00052 (Fisher's exact test), Q value = 0.0025

Table S39.  Gene #8: 'amp_17q25.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 8(17Q25.2) MUTATED 144 21 42 15
AMP PEAK 8(17Q25.2) WILD-TYPE 304 82 148 85

Figure S39.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_17q25.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.003 (Fisher's exact test), Q value = 0.011

Table S40.  Gene #8: 'amp_17q25.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 8(17Q25.2) MUTATED 148 28 50 4
AMP PEAK 8(17Q25.2) WILD-TYPE 314 95 201 11

Figure S40.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_17q25.2' versus 'PATHOLOGY_N_STAGE'

P value = 0.00017 (Fisher's exact test), Q value = 0.00097

Table S41.  Gene #8: 'amp_17q25.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
AMP PEAK 8(17Q25.2) MUTATED 46 16 3
AMP PEAK 8(17Q25.2) WILD-TYPE 271 27 3

Figure S41.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'amp_17q25.2' versus 'GENDER'

P value = 0.000821 (Fisher's exact test), Q value = 0.0038

Table S42.  Gene #8: 'amp_17q25.2' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
AMP PEAK 8(17Q25.2) MUTATED 57 175
AMP PEAK 8(17Q25.2) WILD-TYPE 230 397

Figure S42.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #7: 'GENDER'

'amp_17q25.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S43.  Gene #8: 'amp_17q25.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 8(17Q25.2) MUTATED 1 42 189
AMP PEAK 8(17Q25.2) WILD-TYPE 65 482 80

Figure S43.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_17q25.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0926 (Wilcoxon-test), Q value = 0.2

Table S44.  Gene #8: 'amp_17q25.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
AMP PEAK 8(17Q25.2) MUTATED 33 1970.4 (16.0)
AMP PEAK 8(17Q25.2) WILD-TYPE 34 1976.3 (16.5)

Figure S44.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'amp_17q25.2' versus 'RACE'

P value = 0.0121 (Fisher's exact test), Q value = 0.038

Table S45.  Gene #8: 'amp_17q25.2' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
AMP PEAK 8(17Q25.2) MUTATED 2 6 39 175
AMP PEAK 8(17Q25.2) WILD-TYPE 0 9 77 527

Figure S45.  Get High-res Image Gene #8: 'amp_17q25.2' versus Clinical Feature #12: 'RACE'

'amp_19p13.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00152 (Fisher's exact test), Q value = 0.0066

Table S46.  Gene #9: 'amp_19p13.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 9(19P13.2) MUTATED 35 18 19 19
AMP PEAK 9(19P13.2) WILD-TYPE 413 85 171 81

Figure S46.  Get High-res Image Gene #9: 'amp_19p13.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_19p13.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.00247 (Fisher's exact test), Q value = 0.0098

Table S47.  Gene #9: 'amp_19p13.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 9(19P13.2) MUTATED 37 23 33 3
AMP PEAK 9(19P13.2) WILD-TYPE 425 100 218 12

Figure S47.  Get High-res Image Gene #9: 'amp_19p13.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_19p13.2' versus 'PATHOLOGY_M_STAGE'

P value = 0.0156 (Fisher's exact test), Q value = 0.046

Table S48.  Gene #9: 'amp_19p13.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
AMP PEAK 9(19P13.2) MUTATED 52 17
AMP PEAK 9(19P13.2) WILD-TYPE 490 72

Figure S48.  Get High-res Image Gene #9: 'amp_19p13.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'amp_19p13.2' versus 'HISTOLOGICAL_TYPE'

P value = 0.00034 (Fisher's exact test), Q value = 0.0017

Table S49.  Gene #9: 'amp_19p13.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 9(19P13.2) MUTATED 18 49 30
AMP PEAK 9(19P13.2) WILD-TYPE 48 475 239

Figure S49.  Get High-res Image Gene #9: 'amp_19p13.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_xp22.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.0233 (Fisher's exact test), Q value = 0.065

Table S50.  Gene #10: 'amp_xp22.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 10(XP22.2) MUTATED 72 14 14 15
AMP PEAK 10(XP22.2) WILD-TYPE 376 89 176 85

Figure S50.  Get High-res Image Gene #10: 'amp_xp22.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_xp22.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.0759 (Fisher's exact test), Q value = 0.17

Table S51.  Gene #10: 'amp_xp22.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 10(XP22.2) MUTATED 73 19 24 3
AMP PEAK 10(XP22.2) WILD-TYPE 389 104 227 12

Figure S51.  Get High-res Image Gene #10: 'amp_xp22.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_xp22.2' versus 'GENDER'

P value = 0.00494 (Fisher's exact test), Q value = 0.017

Table S52.  Gene #10: 'amp_xp22.2' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
AMP PEAK 10(XP22.2) MUTATED 27 94
AMP PEAK 10(XP22.2) WILD-TYPE 260 478

Figure S52.  Get High-res Image Gene #10: 'amp_xp22.2' versus Clinical Feature #7: 'GENDER'

'amp_xp22.2' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0254 (Wilcoxon-test), Q value = 0.069

Table S53.  Gene #10: 'amp_xp22.2' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
AMP PEAK 10(XP22.2) MUTATED 26 92.3 (20.3)
AMP PEAK 10(XP22.2) WILD-TYPE 89 89.7 (16.8)

Figure S53.  Get High-res Image Gene #10: 'amp_xp22.2' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'amp_xp22.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S54.  Gene #10: 'amp_xp22.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 10(XP22.2) MUTATED 7 30 84
AMP PEAK 10(XP22.2) WILD-TYPE 59 494 185

Figure S54.  Get High-res Image Gene #10: 'amp_xp22.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_xp22.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.044 (Wilcoxon-test), Q value = 0.11

Table S55.  Gene #10: 'amp_xp22.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
AMP PEAK 10(XP22.2) MUTATED 14 1966.4 (14.1)
AMP PEAK 10(XP22.2) WILD-TYPE 53 1975.3 (16.6)

Figure S55.  Get High-res Image Gene #10: 'amp_xp22.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'amp_xp11.4' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00376 (Fisher's exact test), Q value = 0.014

Table S56.  Gene #11: 'amp_xp11.4' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 11(XP11.4) MUTATED 78 14 13 16
AMP PEAK 11(XP11.4) WILD-TYPE 370 89 177 84

Figure S56.  Get High-res Image Gene #11: 'amp_xp11.4' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_xp11.4' versus 'PATHOLOGY_T_STAGE'

P value = 0.0259 (Fisher's exact test), Q value = 0.069

Table S57.  Gene #11: 'amp_xp11.4' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 11(XP11.4) MUTATED 80 20 24 3
AMP PEAK 11(XP11.4) WILD-TYPE 382 103 227 12

Figure S57.  Get High-res Image Gene #11: 'amp_xp11.4' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_xp11.4' versus 'GENDER'

P value = 0.000532 (Fisher's exact test), Q value = 0.0025

Table S58.  Gene #11: 'amp_xp11.4' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
AMP PEAK 11(XP11.4) MUTATED 26 103
AMP PEAK 11(XP11.4) WILD-TYPE 261 469

Figure S58.  Get High-res Image Gene #11: 'amp_xp11.4' versus Clinical Feature #7: 'GENDER'

'amp_xp11.4' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0254 (Wilcoxon-test), Q value = 0.069

Table S59.  Gene #11: 'amp_xp11.4' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
AMP PEAK 11(XP11.4) MUTATED 26 92.3 (20.3)
AMP PEAK 11(XP11.4) WILD-TYPE 89 89.7 (16.8)

Figure S59.  Get High-res Image Gene #11: 'amp_xp11.4' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'amp_xp11.4' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S60.  Gene #11: 'amp_xp11.4' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 11(XP11.4) MUTATED 7 32 90
AMP PEAK 11(XP11.4) WILD-TYPE 59 492 179

Figure S60.  Get High-res Image Gene #11: 'amp_xp11.4' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_xp11.4' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0579 (Wilcoxon-test), Q value = 0.14

Table S61.  Gene #11: 'amp_xp11.4' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
AMP PEAK 11(XP11.4) MUTATED 15 1966.9 (13.8)
AMP PEAK 11(XP11.4) WILD-TYPE 52 1975.3 (16.8)

Figure S61.  Get High-res Image Gene #11: 'amp_xp11.4' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'amp_xq11.2' versus 'Time to Death'

P value = 0.0918 (logrank test), Q value = 0.2

Table S62.  Gene #12: 'amp_xq11.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
AMP PEAK 12(XQ11.2) MUTATED 122 19 0.1 - 194.8 (25.6)
AMP PEAK 12(XQ11.2) WILD-TYPE 721 192 0.1 - 152.0 (31.3)

Figure S62.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #1: 'Time to Death'

'amp_xq11.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00471 (Fisher's exact test), Q value = 0.017

Table S63.  Gene #12: 'amp_xq11.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 12(XQ11.2) MUTATED 80 14 14 12
AMP PEAK 12(XQ11.2) WILD-TYPE 368 89 176 88

Figure S63.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_xq11.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.00788 (Fisher's exact test), Q value = 0.026

Table S64.  Gene #12: 'amp_xq11.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 12(XQ11.2) MUTATED 82 20 22 2
AMP PEAK 12(XQ11.2) WILD-TYPE 380 103 229 13

Figure S64.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_xq11.2' versus 'GENDER'

P value = 0.000237 (Fisher's exact test), Q value = 0.0013

Table S65.  Gene #12: 'amp_xq11.2' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
AMP PEAK 12(XQ11.2) MUTATED 25 103
AMP PEAK 12(XQ11.2) WILD-TYPE 262 469

Figure S65.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #7: 'GENDER'

'amp_xq11.2' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0254 (Wilcoxon-test), Q value = 0.069

Table S66.  Gene #12: 'amp_xq11.2' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
AMP PEAK 12(XQ11.2) MUTATED 26 92.3 (20.3)
AMP PEAK 12(XQ11.2) WILD-TYPE 89 89.7 (16.8)

Figure S66.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'amp_xq11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S67.  Gene #12: 'amp_xq11.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 12(XQ11.2) MUTATED 7 28 93
AMP PEAK 12(XQ11.2) WILD-TYPE 59 496 176

Figure S67.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'amp_xq11.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0193 (Wilcoxon-test), Q value = 0.056

Table S68.  Gene #12: 'amp_xq11.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
AMP PEAK 12(XQ11.2) MUTATED 16 1965.3 (14.8)
AMP PEAK 12(XQ11.2) WILD-TYPE 51 1975.9 (16.2)

Figure S68.  Get High-res Image Gene #12: 'amp_xq11.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'amp_xq28' versus 'Time to Death'

P value = 0.0777 (logrank test), Q value = 0.17

Table S69.  Gene #13: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
AMP PEAK 13(XQ28) MUTATED 126 20 0.1 - 194.8 (25.5)
AMP PEAK 13(XQ28) WILD-TYPE 717 191 0.1 - 152.0 (31.3)

Figure S69.  Get High-res Image Gene #13: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

'amp_xq28' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.0369 (Fisher's exact test), Q value = 0.094

Table S70.  Gene #13: 'amp_xq28' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
AMP PEAK 13(XQ28) MUTATED 80 12 18 14
AMP PEAK 13(XQ28) WILD-TYPE 368 91 172 86

Figure S70.  Get High-res Image Gene #13: 'amp_xq28' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'amp_xq28' versus 'PATHOLOGY_T_STAGE'

P value = 0.0412 (Fisher's exact test), Q value = 0.1

Table S71.  Gene #13: 'amp_xq28' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
AMP PEAK 13(XQ28) MUTATED 83 19 26 3
AMP PEAK 13(XQ28) WILD-TYPE 379 104 225 12

Figure S71.  Get High-res Image Gene #13: 'amp_xq28' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'amp_xq28' versus 'GENDER'

P value = 0.016 (Fisher's exact test), Q value = 0.047

Table S72.  Gene #13: 'amp_xq28' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
AMP PEAK 13(XQ28) MUTATED 32 100
AMP PEAK 13(XQ28) WILD-TYPE 255 472

Figure S72.  Get High-res Image Gene #13: 'amp_xq28' versus Clinical Feature #7: 'GENDER'

'amp_xq28' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.00192 (Wilcoxon-test), Q value = 0.0081

Table S73.  Gene #13: 'amp_xq28' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
AMP PEAK 13(XQ28) MUTATED 24 97.1 (5.5)
AMP PEAK 13(XQ28) WILD-TYPE 91 88.5 (19.2)

Figure S73.  Get High-res Image Gene #13: 'amp_xq28' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'amp_xq28' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S74.  Gene #13: 'amp_xq28' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
AMP PEAK 13(XQ28) MUTATED 8 37 87
AMP PEAK 13(XQ28) WILD-TYPE 58 487 182

Figure S74.  Get High-res Image Gene #13: 'amp_xq28' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_1p36.31' versus 'YEARS_TO_BIRTH'

P value = 0.0774 (Wilcoxon-test), Q value = 0.17

Table S75.  Gene #14: 'del_1p36.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 1(1P36.31) MUTATED 202 58.4 (13.7)
DEL PEAK 1(1P36.31) WILD-TYPE 651 60.6 (12.2)

Figure S75.  Get High-res Image Gene #14: 'del_1p36.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.31' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S76.  Gene #14: 'del_1p36.31' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 1(1P36.31) MUTATED 71 38 60 29
DEL PEAK 1(1P36.31) WILD-TYPE 377 65 130 71

Figure S76.  Get High-res Image Gene #14: 'del_1p36.31' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_1p36.31' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S77.  Gene #14: 'del_1p36.31' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 1(1P36.31) MUTATED 77 45 73 6
DEL PEAK 1(1P36.31) WILD-TYPE 385 78 178 9

Figure S77.  Get High-res Image Gene #14: 'del_1p36.31' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_1p36.31' versus 'PATHOLOGY_N_STAGE'

P value = 0.0685 (Fisher's exact test), Q value = 0.16

Table S78.  Gene #14: 'del_1p36.31' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 1(1P36.31) MUTATED 92 19 3
DEL PEAK 1(1P36.31) WILD-TYPE 225 24 3

Figure S78.  Get High-res Image Gene #14: 'del_1p36.31' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_1p36.31' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0152 (Wilcoxon-test), Q value = 0.045

Table S79.  Gene #14: 'del_1p36.31' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 1(1P36.31) MUTATED 26 86.2 (19.8)
DEL PEAK 1(1P36.31) WILD-TYPE 89 91.5 (16.8)

Figure S79.  Get High-res Image Gene #14: 'del_1p36.31' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_1p36.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S80.  Gene #14: 'del_1p36.31' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 1(1P36.31) MUTATED 53 101 49
DEL PEAK 1(1P36.31) WILD-TYPE 13 423 220

Figure S80.  Get High-res Image Gene #14: 'del_1p36.31' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_1p31.1' versus 'YEARS_TO_BIRTH'

P value = 0.0352 (Wilcoxon-test), Q value = 0.091

Table S81.  Gene #15: 'del_1p31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 2(1P31.1) MUTATED 161 57.8 (13.8)
DEL PEAK 2(1P31.1) WILD-TYPE 692 60.6 (12.2)

Figure S81.  Get High-res Image Gene #15: 'del_1p31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p31.1' versus 'NEOPLASM_DISEASESTAGE'

P value = 4e-05 (Fisher's exact test), Q value = 0.00028

Table S82.  Gene #15: 'del_1p31.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 2(1P31.1) MUTATED 59 34 43 22
DEL PEAK 2(1P31.1) WILD-TYPE 389 69 147 78

Figure S82.  Get High-res Image Gene #15: 'del_1p31.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_1p31.1' versus 'PATHOLOGY_T_STAGE'

P value = 5e-05 (Fisher's exact test), Q value = 0.00033

Table S83.  Gene #15: 'del_1p31.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 2(1P31.1) MUTATED 64 38 52 6
DEL PEAK 2(1P31.1) WILD-TYPE 398 85 199 9

Figure S83.  Get High-res Image Gene #15: 'del_1p31.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_1p31.1' versus 'PATHOLOGY_N_STAGE'

P value = 0.102 (Fisher's exact test), Q value = 0.21

Table S84.  Gene #15: 'del_1p31.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 2(1P31.1) MUTATED 72 14 3
DEL PEAK 2(1P31.1) WILD-TYPE 245 29 3

Figure S84.  Get High-res Image Gene #15: 'del_1p31.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_1p31.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S85.  Gene #15: 'del_1p31.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 2(1P31.1) MUTATED 53 76 32
DEL PEAK 2(1P31.1) WILD-TYPE 13 448 237

Figure S85.  Get High-res Image Gene #15: 'del_1p31.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_1p31.1' versus 'ETHNICITY'

P value = 0.0856 (Fisher's exact test), Q value = 0.19

Table S86.  Gene #15: 'del_1p31.1' versus Clinical Feature #13: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 42 597
DEL PEAK 2(1P31.1) MUTATED 11 94
DEL PEAK 2(1P31.1) WILD-TYPE 31 503

Figure S86.  Get High-res Image Gene #15: 'del_1p31.1' versus Clinical Feature #13: 'ETHNICITY'

'del_1q43' versus 'Time to Death'

P value = 0.0476 (logrank test), Q value = 0.12

Table S87.  Gene #16: 'del_1q43' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 3(1Q43) MUTATED 111 26 0.1 - 152.0 (47.2)
DEL PEAK 3(1Q43) WILD-TYPE 732 185 0.1 - 194.8 (29.0)

Figure S87.  Get High-res Image Gene #16: 'del_1q43' versus Clinical Feature #1: 'Time to Death'

'del_1q43' versus 'YEARS_TO_BIRTH'

P value = 0.00276 (Wilcoxon-test), Q value = 0.011

Table S88.  Gene #16: 'del_1q43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 3(1Q43) MUTATED 112 56.4 (14.3)
DEL PEAK 3(1Q43) WILD-TYPE 741 60.7 (12.2)

Figure S88.  Get High-res Image Gene #16: 'del_1q43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1q43' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00037 (Fisher's exact test), Q value = 0.0019

Table S89.  Gene #16: 'del_1q43' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 3(1Q43) MUTATED 46 28 23 11
DEL PEAK 3(1Q43) WILD-TYPE 402 75 167 89

Figure S89.  Get High-res Image Gene #16: 'del_1q43' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_1q43' versus 'PATHOLOGY_T_STAGE'

P value = 0.00154 (Fisher's exact test), Q value = 0.0066

Table S90.  Gene #16: 'del_1q43' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 3(1Q43) MUTATED 47 28 31 4
DEL PEAK 3(1Q43) WILD-TYPE 415 95 220 11

Figure S90.  Get High-res Image Gene #16: 'del_1q43' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_1q43' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S91.  Gene #16: 'del_1q43' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 3(1Q43) MUTATED 51 42 19
DEL PEAK 3(1Q43) WILD-TYPE 15 482 250

Figure S91.  Get High-res Image Gene #16: 'del_1q43' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_2q37.3' versus 'Time to Death'

P value = 0.0153 (logrank test), Q value = 0.045

Table S92.  Gene #17: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 4(2Q37.3) MUTATED 108 21 0.4 - 152.0 (42.7)
DEL PEAK 4(2Q37.3) WILD-TYPE 735 190 0.1 - 194.8 (29.0)

Figure S92.  Get High-res Image Gene #17: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

'del_2q37.3' versus 'YEARS_TO_BIRTH'

P value = 0.00203 (Wilcoxon-test), Q value = 0.0083

Table S93.  Gene #17: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 4(2Q37.3) MUTATED 109 56.4 (14.0)
DEL PEAK 4(2Q37.3) WILD-TYPE 744 60.6 (12.3)

Figure S93.  Get High-res Image Gene #17: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q37.3' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S94.  Gene #17: 'del_2q37.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 4(2Q37.3) MUTATED 38 32 28 10
DEL PEAK 4(2Q37.3) WILD-TYPE 410 71 162 90

Figure S94.  Get High-res Image Gene #17: 'del_2q37.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_2q37.3' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S95.  Gene #17: 'del_2q37.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 4(2Q37.3) MUTATED 38 34 34 3
DEL PEAK 4(2Q37.3) WILD-TYPE 424 89 217 12

Figure S95.  Get High-res Image Gene #17: 'del_2q37.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_2q37.3' versus 'PATHOLOGY_M_STAGE'

P value = 0.0853 (Fisher's exact test), Q value = 0.19

Table S96.  Gene #17: 'del_2q37.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 4(2Q37.3) MUTATED 75 6
DEL PEAK 4(2Q37.3) WILD-TYPE 467 83

Figure S96.  Get High-res Image Gene #17: 'del_2q37.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_2q37.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S97.  Gene #17: 'del_2q37.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 4(2Q37.3) MUTATED 49 50 11
DEL PEAK 4(2Q37.3) WILD-TYPE 17 474 258

Figure S97.  Get High-res Image Gene #17: 'del_2q37.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_3p26.3' versus 'Time to Death'

P value = 0.00113 (logrank test), Q value = 0.0051

Table S98.  Gene #18: 'del_3p26.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 5(3P26.3) MUTATED 485 150 0.1 - 141.7 (36.4)
DEL PEAK 5(3P26.3) WILD-TYPE 358 61 0.1 - 194.8 (25.9)

Figure S98.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #1: 'Time to Death'

'del_3p26.3' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S99.  Gene #18: 'del_3p26.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 5(3P26.3) MUTATED 227 57 131 71
DEL PEAK 5(3P26.3) WILD-TYPE 221 46 59 29

Figure S99.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_3p26.3' versus 'PATHOLOGY_T_STAGE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00015

Table S100.  Gene #18: 'del_3p26.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 5(3P26.3) MUTATED 233 71 175 7
DEL PEAK 5(3P26.3) WILD-TYPE 229 52 76 8

Figure S100.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_3p26.3' versus 'PATHOLOGY_N_STAGE'

P value = 0.00885 (Fisher's exact test), Q value = 0.029

Table S101.  Gene #18: 'del_3p26.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 5(3P26.3) MUTATED 212 23 1
DEL PEAK 5(3P26.3) WILD-TYPE 105 20 5

Figure S101.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_3p26.3' versus 'GENDER'

P value = 0.0684 (Fisher's exact test), Q value = 0.16

Table S102.  Gene #18: 'del_3p26.3' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
DEL PEAK 5(3P26.3) MUTATED 175 311
DEL PEAK 5(3P26.3) WILD-TYPE 112 261

Figure S102.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #7: 'GENDER'

'del_3p26.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S103.  Gene #18: 'del_3p26.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 5(3P26.3) MUTATED 10 453 23
DEL PEAK 5(3P26.3) WILD-TYPE 56 71 246

Figure S103.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_3p26.3' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0786 (Wilcoxon-test), Q value = 0.18

Table S104.  Gene #18: 'del_3p26.3' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
DEL PEAK 5(3P26.3) MUTATED 17 1979.4 (18.6)
DEL PEAK 5(3P26.3) WILD-TYPE 50 1971.4 (15.3)

Figure S104.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'del_3p26.3' versus 'RACE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S105.  Gene #18: 'del_3p26.3' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 5(3P26.3) MUTATED 0 7 41 429
DEL PEAK 5(3P26.3) WILD-TYPE 2 8 75 273

Figure S105.  Get High-res Image Gene #18: 'del_3p26.3' versus Clinical Feature #12: 'RACE'

'del_3p21.2' versus 'Time to Death'

P value = 7.97e-06 (logrank test), Q value = 7.6e-05

Table S106.  Gene #19: 'del_3p21.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 6(3P21.2) MUTATED 498 160 0.1 - 141.7 (35.1)
DEL PEAK 6(3P21.2) WILD-TYPE 345 51 0.1 - 194.8 (26.4)

Figure S106.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #1: 'Time to Death'

'del_3p21.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S107.  Gene #19: 'del_3p21.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 6(3P21.2) MUTATED 227 57 137 78
DEL PEAK 6(3P21.2) WILD-TYPE 221 46 53 22

Figure S107.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_3p21.2' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S108.  Gene #19: 'del_3p21.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 6(3P21.2) MUTATED 233 71 188 7
DEL PEAK 6(3P21.2) WILD-TYPE 229 52 63 8

Figure S108.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_3p21.2' versus 'PATHOLOGY_N_STAGE'

P value = 0.0986 (Fisher's exact test), Q value = 0.21

Table S109.  Gene #19: 'del_3p21.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 6(3P21.2) MUTATED 218 26 2
DEL PEAK 6(3P21.2) WILD-TYPE 99 17 4

Figure S109.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_3p21.2' versus 'PATHOLOGY_M_STAGE'

P value = 0.0049 (Fisher's exact test), Q value = 0.017

Table S110.  Gene #19: 'del_3p21.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 6(3P21.2) MUTATED 379 75
DEL PEAK 6(3P21.2) WILD-TYPE 163 14

Figure S110.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_3p21.2' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0596 (Wilcoxon-test), Q value = 0.14

Table S111.  Gene #19: 'del_3p21.2' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 6(3P21.2) MUTATED 48 86.0 (24.0)
DEL PEAK 6(3P21.2) WILD-TYPE 67 93.3 (10.1)

Figure S111.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_3p21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S112.  Gene #19: 'del_3p21.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 6(3P21.2) MUTATED 11 463 25
DEL PEAK 6(3P21.2) WILD-TYPE 55 61 244

Figure S112.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_3p21.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0343 (Wilcoxon-test), Q value = 0.089

Table S113.  Gene #19: 'del_3p21.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
DEL PEAK 6(3P21.2) MUTATED 18 1980.1 (17.8)
DEL PEAK 6(3P21.2) WILD-TYPE 49 1971.0 (15.3)

Figure S113.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'del_3p21.2' versus 'RACE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S114.  Gene #19: 'del_3p21.2' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 6(3P21.2) MUTATED 0 8 41 442
DEL PEAK 6(3P21.2) WILD-TYPE 2 7 75 260

Figure S114.  Get High-res Image Gene #19: 'del_3p21.2' versus Clinical Feature #12: 'RACE'

'del_3p14.1' versus 'Time to Death'

P value = 0.00206 (logrank test), Q value = 0.0083

Table S115.  Gene #20: 'del_3p14.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 7(3P14.1) MUTATED 405 128 0.1 - 141.7 (36.4)
DEL PEAK 7(3P14.1) WILD-TYPE 438 83 0.1 - 194.8 (27.1)

Figure S115.  Get High-res Image Gene #20: 'del_3p14.1' versus Clinical Feature #1: 'Time to Death'

'del_3p14.1' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00023 (Fisher's exact test), Q value = 0.0012

Table S116.  Gene #20: 'del_3p14.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 7(3P14.1) MUTATED 187 49 112 57
DEL PEAK 7(3P14.1) WILD-TYPE 261 54 78 43

Figure S116.  Get High-res Image Gene #20: 'del_3p14.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_3p14.1' versus 'PATHOLOGY_T_STAGE'

P value = 6e-05 (Fisher's exact test), Q value = 0.00038

Table S117.  Gene #20: 'del_3p14.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 7(3P14.1) MUTATED 191 60 149 5
DEL PEAK 7(3P14.1) WILD-TYPE 271 63 102 10

Figure S117.  Get High-res Image Gene #20: 'del_3p14.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_3p14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S118.  Gene #20: 'del_3p14.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 7(3P14.1) MUTATED 11 371 23
DEL PEAK 7(3P14.1) WILD-TYPE 55 153 246

Figure S118.  Get High-res Image Gene #20: 'del_3p14.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_3p14.1' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.055 (Wilcoxon-test), Q value = 0.13

Table S119.  Gene #20: 'del_3p14.1' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
DEL PEAK 7(3P14.1) MUTATED 15 1980.1 (18.7)
DEL PEAK 7(3P14.1) WILD-TYPE 52 1971.5 (15.3)

Figure S119.  Get High-res Image Gene #20: 'del_3p14.1' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'del_3p14.1' versus 'RACE'

P value = 0.00013 (Fisher's exact test), Q value = 0.00076

Table S120.  Gene #20: 'del_3p14.1' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 7(3P14.1) MUTATED 0 7 35 356
DEL PEAK 7(3P14.1) WILD-TYPE 2 8 81 346

Figure S120.  Get High-res Image Gene #20: 'del_3p14.1' versus Clinical Feature #12: 'RACE'

'del_3p12.2' versus 'Time to Death'

P value = 0.00116 (logrank test), Q value = 0.0052

Table S121.  Gene #21: 'del_3p12.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 8(3P12.2) MUTATED 334 109 0.1 - 141.7 (36.7)
DEL PEAK 8(3P12.2) WILD-TYPE 509 102 0.1 - 194.8 (27.6)

Figure S121.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #1: 'Time to Death'

'del_3p12.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.0127 (Fisher's exact test), Q value = 0.039

Table S122.  Gene #21: 'del_3p12.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 8(3P12.2) MUTATED 156 42 89 47
DEL PEAK 8(3P12.2) WILD-TYPE 292 61 101 53

Figure S122.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_3p12.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.00642 (Fisher's exact test), Q value = 0.022

Table S123.  Gene #21: 'del_3p12.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 8(3P12.2) MUTATED 160 51 119 4
DEL PEAK 8(3P12.2) WILD-TYPE 302 72 132 11

Figure S123.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_3p12.2' versus 'GENDER'

P value = 0.0884 (Fisher's exact test), Q value = 0.19

Table S124.  Gene #21: 'del_3p12.2' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
DEL PEAK 8(3P12.2) MUTATED 100 234
DEL PEAK 8(3P12.2) WILD-TYPE 187 338

Figure S124.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #7: 'GENDER'

'del_3p12.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S125.  Gene #21: 'del_3p12.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 8(3P12.2) MUTATED 11 304 19
DEL PEAK 8(3P12.2) WILD-TYPE 55 220 250

Figure S125.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_3p12.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.0826 (Wilcoxon-test), Q value = 0.18

Table S126.  Gene #21: 'del_3p12.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
DEL PEAK 8(3P12.2) MUTATED 11 1980.5 (17.8)
DEL PEAK 8(3P12.2) WILD-TYPE 56 1972.0 (15.9)

Figure S126.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'del_3p12.2' versus 'RACE'

P value = 0.00473 (Fisher's exact test), Q value = 0.017

Table S127.  Gene #21: 'del_3p12.2' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 8(3P12.2) MUTATED 0 6 30 292
DEL PEAK 8(3P12.2) WILD-TYPE 2 9 86 410

Figure S127.  Get High-res Image Gene #21: 'del_3p12.2' versus Clinical Feature #12: 'RACE'

'del_4q34.3' versus 'Time to Death'

P value = 7.22e-09 (logrank test), Q value = 8.8e-07

Table S128.  Gene #22: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 9(4Q34.3) MUTATED 110 50 0.1 - 112.8 (22.8)
DEL PEAK 9(4Q34.3) WILD-TYPE 733 161 0.1 - 194.8 (30.6)

Figure S128.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

'del_4q34.3' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S129.  Gene #22: 'del_4q34.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 9(4Q34.3) MUTATED 26 10 48 24
DEL PEAK 9(4Q34.3) WILD-TYPE 422 93 142 76

Figure S129.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_4q34.3' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S130.  Gene #22: 'del_4q34.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 9(4Q34.3) MUTATED 29 14 59 7
DEL PEAK 9(4Q34.3) WILD-TYPE 433 109 192 8

Figure S130.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_4q34.3' versus 'PATHOLOGY_N_STAGE'

P value = 0.0109 (Fisher's exact test), Q value = 0.035

Table S131.  Gene #22: 'del_4q34.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 9(4Q34.3) MUTATED 40 13 0
DEL PEAK 9(4Q34.3) WILD-TYPE 277 30 6

Figure S131.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_4q34.3' versus 'PATHOLOGY_M_STAGE'

P value = 0.0143 (Fisher's exact test), Q value = 0.043

Table S132.  Gene #22: 'del_4q34.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 9(4Q34.3) MUTATED 71 21
DEL PEAK 9(4Q34.3) WILD-TYPE 471 68

Figure S132.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_4q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.0318 (Fisher's exact test), Q value = 0.084

Table S133.  Gene #22: 'del_4q34.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 9(4Q34.3) MUTATED 3 78 30
DEL PEAK 9(4Q34.3) WILD-TYPE 63 446 239

Figure S133.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_4q34.3' versus 'RACE'

P value = 0.0647 (Fisher's exact test), Q value = 0.15

Table S134.  Gene #22: 'del_4q34.3' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 9(4Q34.3) MUTATED 0 4 8 93
DEL PEAK 9(4Q34.3) WILD-TYPE 2 11 108 609

Figure S134.  Get High-res Image Gene #22: 'del_4q34.3' versus Clinical Feature #12: 'RACE'

'del_5p15.33' versus 'YEARS_TO_BIRTH'

P value = 0.00445 (Wilcoxon-test), Q value = 0.016

Table S135.  Gene #23: 'del_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 10(5P15.33) MUTATED 30 52.4 (14.6)
DEL PEAK 10(5P15.33) WILD-TYPE 823 60.4 (12.4)

Figure S135.  Get High-res Image Gene #23: 'del_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_5p15.33' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00148 (Fisher's exact test), Q value = 0.0065

Table S136.  Gene #23: 'del_5p15.33' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 10(5P15.33) MUTATED 7 9 9 5
DEL PEAK 10(5P15.33) WILD-TYPE 441 94 181 95

Figure S136.  Get High-res Image Gene #23: 'del_5p15.33' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_5p15.33' versus 'PATHOLOGY_T_STAGE'

P value = 0.00057 (Fisher's exact test), Q value = 0.0027

Table S137.  Gene #23: 'del_5p15.33' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 10(5P15.33) MUTATED 7 11 13 0
DEL PEAK 10(5P15.33) WILD-TYPE 455 112 238 15

Figure S137.  Get High-res Image Gene #23: 'del_5p15.33' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_5p15.33' versus 'PATHOLOGY_N_STAGE'

P value = 0.00573 (Fisher's exact test), Q value = 0.02

Table S138.  Gene #23: 'del_5p15.33' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 10(5P15.33) MUTATED 13 5 2
DEL PEAK 10(5P15.33) WILD-TYPE 304 38 4

Figure S138.  Get High-res Image Gene #23: 'del_5p15.33' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_5p15.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S139.  Gene #23: 'del_5p15.33' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 10(5P15.33) MUTATED 10 8 13
DEL PEAK 10(5P15.33) WILD-TYPE 56 516 256

Figure S139.  Get High-res Image Gene #23: 'del_5p15.33' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_6q22.31' versus 'YEARS_TO_BIRTH'

P value = 0.124 (Wilcoxon-test), Q value = 0.25

Table S140.  Gene #24: 'del_6q22.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 11(6Q22.31) MUTATED 223 58.6 (13.8)
DEL PEAK 11(6Q22.31) WILD-TYPE 630 60.6 (12.1)

Figure S140.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_6q22.31' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00013 (Fisher's exact test), Q value = 0.00076

Table S141.  Gene #24: 'del_6q22.31' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 11(6Q22.31) MUTATED 93 41 55 35
DEL PEAK 11(6Q22.31) WILD-TYPE 355 62 135 65

Figure S141.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_6q22.31' versus 'PATHOLOGY_T_STAGE'

P value = 4e-05 (Fisher's exact test), Q value = 0.00028

Table S142.  Gene #24: 'del_6q22.31' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 11(6Q22.31) MUTATED 94 44 80 7
DEL PEAK 11(6Q22.31) WILD-TYPE 368 79 171 8

Figure S142.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_6q22.31' versus 'PATHOLOGY_N_STAGE'

P value = 0.0357 (Fisher's exact test), Q value = 0.092

Table S143.  Gene #24: 'del_6q22.31' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 11(6Q22.31) MUTATED 87 17 4
DEL PEAK 11(6Q22.31) WILD-TYPE 230 26 2

Figure S143.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_6q22.31' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.107 (Wilcoxon-test), Q value = 0.22

Table S144.  Gene #24: 'del_6q22.31' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 11(6Q22.31) MUTATED 32 85.6 (24.2)
DEL PEAK 11(6Q22.31) WILD-TYPE 83 92.0 (14.0)

Figure S144.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_6q22.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S145.  Gene #24: 'del_6q22.31' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 11(6Q22.31) MUTATED 51 147 27
DEL PEAK 11(6Q22.31) WILD-TYPE 15 377 242

Figure S145.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_6q22.31' versus 'RACE'

P value = 0.00221 (Fisher's exact test), Q value = 0.0088

Table S146.  Gene #24: 'del_6q22.31' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 11(6Q22.31) MUTATED 0 6 16 195
DEL PEAK 11(6Q22.31) WILD-TYPE 2 9 100 507

Figure S146.  Get High-res Image Gene #24: 'del_6q22.31' versus Clinical Feature #12: 'RACE'

'del_6q26' versus 'NEOPLASM_DISEASESTAGE'

P value = 6e-05 (Fisher's exact test), Q value = 0.00038

Table S147.  Gene #25: 'del_6q26' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 12(6Q26) MUTATED 94 43 58 34
DEL PEAK 12(6Q26) WILD-TYPE 354 60 132 66

Figure S147.  Get High-res Image Gene #25: 'del_6q26' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_6q26' versus 'PATHOLOGY_T_STAGE'

P value = 5e-05 (Fisher's exact test), Q value = 0.00033

Table S148.  Gene #25: 'del_6q26' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 12(6Q26) MUTATED 95 46 83 6
DEL PEAK 12(6Q26) WILD-TYPE 367 77 168 9

Figure S148.  Get High-res Image Gene #25: 'del_6q26' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_6q26' versus 'PATHOLOGY_N_STAGE'

P value = 0.0548 (Fisher's exact test), Q value = 0.13

Table S149.  Gene #25: 'del_6q26' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 12(6Q26) MUTATED 92 17 4
DEL PEAK 12(6Q26) WILD-TYPE 225 26 2

Figure S149.  Get High-res Image Gene #25: 'del_6q26' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_6q26' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.086 (Wilcoxon-test), Q value = 0.19

Table S150.  Gene #25: 'del_6q26' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 12(6Q26) MUTATED 33 85.8 (23.9)
DEL PEAK 12(6Q26) WILD-TYPE 82 92.1 (14.1)

Figure S150.  Get High-res Image Gene #25: 'del_6q26' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_6q26' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S151.  Gene #25: 'del_6q26' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 12(6Q26) MUTATED 51 151 28
DEL PEAK 12(6Q26) WILD-TYPE 15 373 241

Figure S151.  Get High-res Image Gene #25: 'del_6q26' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_6q26' versus 'RACE'

P value = 0.00126 (Fisher's exact test), Q value = 0.0056

Table S152.  Gene #25: 'del_6q26' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 12(6Q26) MUTATED 0 6 16 200
DEL PEAK 12(6Q26) WILD-TYPE 2 9 100 502

Figure S152.  Get High-res Image Gene #25: 'del_6q26' versus Clinical Feature #12: 'RACE'

'del_6q26' versus 'NEOPLASM_DISEASESTAGE'

P value = 8e-05 (Fisher's exact test), Q value = 5e-04

Table S153.  Gene #26: 'del_6q26' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 13(6Q26) MUTATED 95 43 58 34
DEL PEAK 13(6Q26) WILD-TYPE 353 60 132 66

Figure S153.  Get High-res Image Gene #26: 'del_6q26' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_6q26' versus 'PATHOLOGY_T_STAGE'

P value = 6e-05 (Fisher's exact test), Q value = 0.00038

Table S154.  Gene #26: 'del_6q26' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 13(6Q26) MUTATED 96 46 83 6
DEL PEAK 13(6Q26) WILD-TYPE 366 77 168 9

Figure S154.  Get High-res Image Gene #26: 'del_6q26' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_6q26' versus 'PATHOLOGY_N_STAGE'

P value = 0.0549 (Fisher's exact test), Q value = 0.13

Table S155.  Gene #26: 'del_6q26' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 13(6Q26) MUTATED 92 17 4
DEL PEAK 13(6Q26) WILD-TYPE 225 26 2

Figure S155.  Get High-res Image Gene #26: 'del_6q26' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_6q26' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.086 (Wilcoxon-test), Q value = 0.19

Table S156.  Gene #26: 'del_6q26' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 13(6Q26) MUTATED 33 85.8 (23.9)
DEL PEAK 13(6Q26) WILD-TYPE 82 92.1 (14.1)

Figure S156.  Get High-res Image Gene #26: 'del_6q26' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_6q26' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S157.  Gene #26: 'del_6q26' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 13(6Q26) MUTATED 51 151 29
DEL PEAK 13(6Q26) WILD-TYPE 15 373 240

Figure S157.  Get High-res Image Gene #26: 'del_6q26' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_6q26' versus 'RACE'

P value = 0.00323 (Fisher's exact test), Q value = 0.012

Table S158.  Gene #26: 'del_6q26' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 13(6Q26) MUTATED 0 6 17 200
DEL PEAK 13(6Q26) WILD-TYPE 2 9 99 502

Figure S158.  Get High-res Image Gene #26: 'del_6q26' versus Clinical Feature #12: 'RACE'

'del_8p23.2' versus 'Time to Death'

P value = 0.000909 (logrank test), Q value = 0.0042

Table S159.  Gene #27: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 14(8P23.2) MUTATED 181 63 0.1 - 137.1 (31.9)
DEL PEAK 14(8P23.2) WILD-TYPE 662 148 0.1 - 194.8 (30.3)

Figure S159.  Get High-res Image Gene #27: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

'del_8p23.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00201 (Fisher's exact test), Q value = 0.0083

Table S160.  Gene #27: 'del_8p23.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 14(8P23.2) MUTATED 75 25 48 32
DEL PEAK 14(8P23.2) WILD-TYPE 373 78 142 68

Figure S160.  Get High-res Image Gene #27: 'del_8p23.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_8p23.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.00183 (Fisher's exact test), Q value = 0.0078

Table S161.  Gene #27: 'del_8p23.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 14(8P23.2) MUTATED 77 30 68 6
DEL PEAK 14(8P23.2) WILD-TYPE 385 93 183 9

Figure S161.  Get High-res Image Gene #27: 'del_8p23.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_8p23.2' versus 'PATHOLOGY_M_STAGE'

P value = 0.0257 (Fisher's exact test), Q value = 0.069

Table S162.  Gene #27: 'del_8p23.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 14(8P23.2) MUTATED 131 32
DEL PEAK 14(8P23.2) WILD-TYPE 411 57

Figure S162.  Get High-res Image Gene #27: 'del_8p23.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_8p23.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S163.  Gene #27: 'del_8p23.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 14(8P23.2) MUTATED 12 154 15
DEL PEAK 14(8P23.2) WILD-TYPE 54 370 254

Figure S163.  Get High-res Image Gene #27: 'del_8p23.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'RACE'

P value = 0.00376 (Fisher's exact test), Q value = 0.014

Table S164.  Gene #27: 'del_8p23.2' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 14(8P23.2) MUTATED 0 7 14 157
DEL PEAK 14(8P23.2) WILD-TYPE 2 8 102 545

Figure S164.  Get High-res Image Gene #27: 'del_8p23.2' versus Clinical Feature #12: 'RACE'

'del_9p23' versus 'Time to Death'

P value = 2.91e-11 (logrank test), Q value = 4.9e-09

Table S165.  Gene #28: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 15(9P23) MUTATED 193 85 0.1 - 141.7 (31.3)
DEL PEAK 15(9P23) WILD-TYPE 650 126 0.1 - 194.8 (30.3)

Figure S165.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

'del_9p23' versus 'YEARS_TO_BIRTH'

P value = 0.0247 (Wilcoxon-test), Q value = 0.068

Table S166.  Gene #28: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 15(9P23) MUTATED 194 61.8 (12.0)
DEL PEAK 15(9P23) WILD-TYPE 659 59.6 (12.7)

Figure S166.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9p23' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S167.  Gene #28: 'del_9p23' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 15(9P23) MUTATED 64 16 69 43
DEL PEAK 15(9P23) WILD-TYPE 384 87 121 57

Figure S167.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_9p23' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S168.  Gene #28: 'del_9p23' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 15(9P23) MUTATED 68 23 96 7
DEL PEAK 15(9P23) WILD-TYPE 394 100 155 8

Figure S168.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_9p23' versus 'PATHOLOGY_N_STAGE'

P value = 0.00724 (Fisher's exact test), Q value = 0.024

Table S169.  Gene #28: 'del_9p23' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 15(9P23) MUTATED 71 19 2
DEL PEAK 15(9P23) WILD-TYPE 246 24 4

Figure S169.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_9p23' versus 'PATHOLOGY_M_STAGE'

P value = 0.000223 (Fisher's exact test), Q value = 0.0012

Table S170.  Gene #28: 'del_9p23' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 15(9P23) MUTATED 126 38
DEL PEAK 15(9P23) WILD-TYPE 416 51

Figure S170.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_9p23' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0204 (Wilcoxon-test), Q value = 0.059

Table S171.  Gene #28: 'del_9p23' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 15(9P23) MUTATED 23 83.0 (27.0)
DEL PEAK 15(9P23) WILD-TYPE 92 92.1 (13.9)

Figure S171.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_9p23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S172.  Gene #28: 'del_9p23' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 15(9P23) MUTATED 10 151 35
DEL PEAK 15(9P23) WILD-TYPE 56 373 234

Figure S172.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_9p23' versus 'RACE'

P value = 0.0126 (Fisher's exact test), Q value = 0.039

Table S173.  Gene #28: 'del_9p23' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 15(9P23) MUTATED 0 4 14 172
DEL PEAK 15(9P23) WILD-TYPE 2 11 102 530

Figure S173.  Get High-res Image Gene #28: 'del_9p23' versus Clinical Feature #12: 'RACE'

'del_9p21.3' versus 'Time to Death'

P value = 1.12e-14 (logrank test), Q value = 5.7e-12

Table S174.  Gene #29: 'del_9p21.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 16(9P21.3) MUTATED 203 93 0.1 - 141.7 (28.9)
DEL PEAK 16(9P21.3) WILD-TYPE 640 118 0.1 - 194.8 (30.7)

Figure S174.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #1: 'Time to Death'

'del_9p21.3' versus 'YEARS_TO_BIRTH'

P value = 0.0358 (Wilcoxon-test), Q value = 0.092

Table S175.  Gene #29: 'del_9p21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 16(9P21.3) MUTATED 205 61.6 (12.2)
DEL PEAK 16(9P21.3) WILD-TYPE 648 59.6 (12.7)

Figure S175.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9p21.3' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S176.  Gene #29: 'del_9p21.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 16(9P21.3) MUTATED 66 15 74 48
DEL PEAK 16(9P21.3) WILD-TYPE 382 88 116 52

Figure S176.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_9p21.3' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S177.  Gene #29: 'del_9p21.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 16(9P21.3) MUTATED 70 22 105 8
DEL PEAK 16(9P21.3) WILD-TYPE 392 101 146 7

Figure S177.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_9p21.3' versus 'PATHOLOGY_N_STAGE'

P value = 0.00013 (Fisher's exact test), Q value = 0.00076

Table S178.  Gene #29: 'del_9p21.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 16(9P21.3) MUTATED 77 24 2
DEL PEAK 16(9P21.3) WILD-TYPE 240 19 4

Figure S178.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_9p21.3' versus 'PATHOLOGY_M_STAGE'

P value = 9.23e-06 (Fisher's exact test), Q value = 7.6e-05

Table S179.  Gene #29: 'del_9p21.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 16(9P21.3) MUTATED 131 43
DEL PEAK 16(9P21.3) WILD-TYPE 411 46

Figure S179.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_9p21.3' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0401 (Wilcoxon-test), Q value = 0.1

Table S180.  Gene #29: 'del_9p21.3' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 16(9P21.3) MUTATED 24 83.8 (26.7)
DEL PEAK 16(9P21.3) WILD-TYPE 91 92.0 (14.0)

Figure S180.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_9p21.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S181.  Gene #29: 'del_9p21.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 16(9P21.3) MUTATED 10 159 38
DEL PEAK 16(9P21.3) WILD-TYPE 56 365 231

Figure S181.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_9p21.3' versus 'RACE'

P value = 0.00827 (Fisher's exact test), Q value = 0.027

Table S182.  Gene #29: 'del_9p21.3' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 16(9P21.3) MUTATED 0 3 15 184
DEL PEAK 16(9P21.3) WILD-TYPE 2 12 101 518

Figure S182.  Get High-res Image Gene #29: 'del_9p21.3' versus Clinical Feature #12: 'RACE'

'del_10q23.31' versus 'YEARS_TO_BIRTH'

P value = 0.0425 (Wilcoxon-test), Q value = 0.11

Table S183.  Gene #30: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 17(10Q23.31) MUTATED 160 58.0 (14.0)
DEL PEAK 17(10Q23.31) WILD-TYPE 693 60.6 (12.2)

Figure S183.  Get High-res Image Gene #30: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_10q23.31' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S184.  Gene #30: 'del_10q23.31' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 17(10Q23.31) MUTATED 52 32 53 25
DEL PEAK 17(10Q23.31) WILD-TYPE 396 71 137 75

Figure S184.  Get High-res Image Gene #30: 'del_10q23.31' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_10q23.31' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S185.  Gene #30: 'del_10q23.31' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 17(10Q23.31) MUTATED 53 33 69 7
DEL PEAK 17(10Q23.31) WILD-TYPE 409 90 182 8

Figure S185.  Get High-res Image Gene #30: 'del_10q23.31' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_10q23.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S186.  Gene #30: 'del_10q23.31' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 17(10Q23.31) MUTATED 49 96 17
DEL PEAK 17(10Q23.31) WILD-TYPE 17 428 252

Figure S186.  Get High-res Image Gene #30: 'del_10q23.31' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_10q23.31' versus 'RACE'

P value = 0.0994 (Fisher's exact test), Q value = 0.21

Table S187.  Gene #30: 'del_10q23.31' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 17(10Q23.31) MUTATED 0 4 13 139
DEL PEAK 17(10Q23.31) WILD-TYPE 2 11 103 563

Figure S187.  Get High-res Image Gene #30: 'del_10q23.31' versus Clinical Feature #12: 'RACE'

'del_11q21' versus 'Time to Death'

P value = 0.00196 (logrank test), Q value = 0.0082

Table S188.  Gene #31: 'del_11q21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 18(11Q21) MUTATED 59 22 0.1 - 123.6 (19.7)
DEL PEAK 18(11Q21) WILD-TYPE 784 189 0.1 - 194.8 (31.1)

Figure S188.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #1: 'Time to Death'

'del_11q21' versus 'YEARS_TO_BIRTH'

P value = 0.00478 (Wilcoxon-test), Q value = 0.017

Table S189.  Gene #31: 'del_11q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 18(11Q21) MUTATED 59 64.2 (11.0)
DEL PEAK 18(11Q21) WILD-TYPE 794 59.8 (12.6)

Figure S189.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q21' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00026 (Fisher's exact test), Q value = 0.0014

Table S190.  Gene #31: 'del_11q21' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 18(11Q21) MUTATED 16 11 20 12
DEL PEAK 18(11Q21) WILD-TYPE 432 92 170 88

Figure S190.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_11q21' versus 'PATHOLOGY_T_STAGE'

P value = 0.00041 (Fisher's exact test), Q value = 0.0021

Table S191.  Gene #31: 'del_11q21' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 18(11Q21) MUTATED 17 12 29 1
DEL PEAK 18(11Q21) WILD-TYPE 445 111 222 14

Figure S191.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_11q21' versus 'PATHOLOGY_N_STAGE'

P value = 0.00019 (Fisher's exact test), Q value = 0.0011

Table S192.  Gene #31: 'del_11q21' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 18(11Q21) MUTATED 21 11 2
DEL PEAK 18(11Q21) WILD-TYPE 296 32 4

Figure S192.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_11q21' versus 'PATHOLOGY_M_STAGE'

P value = 0.0998 (Fisher's exact test), Q value = 0.21

Table S193.  Gene #31: 'del_11q21' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 18(11Q21) MUTATED 30 9
DEL PEAK 18(11Q21) WILD-TYPE 512 80

Figure S193.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_11q21' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0624 (Wilcoxon-test), Q value = 0.15

Table S194.  Gene #31: 'del_11q21' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 18(11Q21) MUTATED 11 89.1 (7.0)
DEL PEAK 18(11Q21) WILD-TYPE 104 90.4 (18.4)

Figure S194.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_11q21' versus 'HISTOLOGICAL_TYPE'

P value = 0.00304 (Fisher's exact test), Q value = 0.011

Table S195.  Gene #31: 'del_11q21' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 18(11Q21) MUTATED 9 25 26
DEL PEAK 18(11Q21) WILD-TYPE 57 499 243

Figure S195.  Get High-res Image Gene #31: 'del_11q21' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_11q23.1' versus 'Time to Death'

P value = 0.00373 (logrank test), Q value = 0.014

Table S196.  Gene #32: 'del_11q23.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 19(11Q23.1) MUTATED 68 25 0.1 - 123.6 (20.6)
DEL PEAK 19(11Q23.1) WILD-TYPE 775 186 0.1 - 194.8 (30.7)

Figure S196.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #1: 'Time to Death'

'del_11q23.1' versus 'YEARS_TO_BIRTH'

P value = 0.00293 (Wilcoxon-test), Q value = 0.011

Table S197.  Gene #32: 'del_11q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 19(11Q23.1) MUTATED 69 64.1 (11.0)
DEL PEAK 19(11Q23.1) WILD-TYPE 784 59.8 (12.6)

Figure S197.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q23.1' versus 'NEOPLASM_DISEASESTAGE'

P value = 3e-05 (Fisher's exact test), Q value = 0.00021

Table S198.  Gene #32: 'del_11q23.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 19(11Q23.1) MUTATED 18 13 24 14
DEL PEAK 19(11Q23.1) WILD-TYPE 430 90 166 86

Figure S198.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_11q23.1' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S199.  Gene #32: 'del_11q23.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 19(11Q23.1) MUTATED 19 15 32 3
DEL PEAK 19(11Q23.1) WILD-TYPE 443 108 219 12

Figure S199.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_11q23.1' versus 'PATHOLOGY_N_STAGE'

P value = 0.00047 (Fisher's exact test), Q value = 0.0023

Table S200.  Gene #32: 'del_11q23.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 19(11Q23.1) MUTATED 24 11 2
DEL PEAK 19(11Q23.1) WILD-TYPE 293 32 4

Figure S200.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_11q23.1' versus 'PATHOLOGY_M_STAGE'

P value = 0.112 (Fisher's exact test), Q value = 0.23

Table S201.  Gene #32: 'del_11q23.1' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 19(11Q23.1) MUTATED 34 10
DEL PEAK 19(11Q23.1) WILD-TYPE 508 79

Figure S201.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_11q23.1' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0253 (Wilcoxon-test), Q value = 0.069

Table S202.  Gene #32: 'del_11q23.1' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 19(11Q23.1) MUTATED 12 88.3 (7.2)
DEL PEAK 19(11Q23.1) WILD-TYPE 103 90.5 (18.4)

Figure S202.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_11q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 0.00361 (Fisher's exact test), Q value = 0.013

Table S203.  Gene #32: 'del_11q23.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 19(11Q23.1) MUTATED 9 30 31
DEL PEAK 19(11Q23.1) WILD-TYPE 57 494 238

Figure S203.  Get High-res Image Gene #32: 'del_11q23.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_13q12.13' versus 'Time to Death'

P value = 0.0323 (logrank test), Q value = 0.085

Table S204.  Gene #33: 'del_13q12.13' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 20(13Q12.13) MUTATED 146 53 0.1 - 152.0 (36.7)
DEL PEAK 20(13Q12.13) WILD-TYPE 697 158 0.1 - 194.8 (29.5)

Figure S204.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #1: 'Time to Death'

'del_13q12.13' versus 'YEARS_TO_BIRTH'

P value = 0.000423 (Wilcoxon-test), Q value = 0.0021

Table S205.  Gene #33: 'del_13q12.13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 20(13Q12.13) MUTATED 148 56.2 (15.2)
DEL PEAK 20(13Q12.13) WILD-TYPE 705 60.9 (11.8)

Figure S205.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q12.13' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S206.  Gene #33: 'del_13q12.13' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 20(13Q12.13) MUTATED 46 24 50 28
DEL PEAK 20(13Q12.13) WILD-TYPE 402 79 140 72

Figure S206.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_13q12.13' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S207.  Gene #33: 'del_13q12.13' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 20(13Q12.13) MUTATED 48 26 65 9
DEL PEAK 20(13Q12.13) WILD-TYPE 414 97 186 6

Figure S207.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_13q12.13' versus 'PATHOLOGY_N_STAGE'

P value = 0.0135 (Fisher's exact test), Q value = 0.041

Table S208.  Gene #33: 'del_13q12.13' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 20(13Q12.13) MUTATED 68 14 4
DEL PEAK 20(13Q12.13) WILD-TYPE 249 29 2

Figure S208.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_13q12.13' versus 'GENDER'

P value = 0.0212 (Fisher's exact test), Q value = 0.06

Table S209.  Gene #33: 'del_13q12.13' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
DEL PEAK 20(13Q12.13) MUTATED 62 86
DEL PEAK 20(13Q12.13) WILD-TYPE 225 486

Figure S209.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #7: 'GENDER'

'del_13q12.13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S210.  Gene #33: 'del_13q12.13' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 20(13Q12.13) MUTATED 44 81 23
DEL PEAK 20(13Q12.13) WILD-TYPE 22 443 246

Figure S210.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_13q12.13' versus 'RACE'

P value = 0.103 (Fisher's exact test), Q value = 0.21

Table S211.  Gene #33: 'del_13q12.13' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 20(13Q12.13) MUTATED 0 4 12 127
DEL PEAK 20(13Q12.13) WILD-TYPE 2 11 104 575

Figure S211.  Get High-res Image Gene #33: 'del_13q12.13' versus Clinical Feature #12: 'RACE'

'del_13q14.2' versus 'Time to Death'

P value = 0.0241 (logrank test), Q value = 0.067

Table S212.  Gene #34: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 21(13Q14.2) MUTATED 146 53 0.1 - 152.0 (33.7)
DEL PEAK 21(13Q14.2) WILD-TYPE 697 158 0.1 - 194.8 (29.9)

Figure S212.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

'del_13q14.2' versus 'YEARS_TO_BIRTH'

P value = 8.11e-05 (Wilcoxon-test), Q value = 5e-04

Table S213.  Gene #34: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 21(13Q14.2) MUTATED 148 55.7 (15.0)
DEL PEAK 21(13Q14.2) WILD-TYPE 705 61.0 (11.8)

Figure S213.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q14.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S214.  Gene #34: 'del_13q14.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 21(13Q14.2) MUTATED 46 22 51 29
DEL PEAK 21(13Q14.2) WILD-TYPE 402 81 139 71

Figure S214.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_13q14.2' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S215.  Gene #34: 'del_13q14.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 21(13Q14.2) MUTATED 48 24 67 9
DEL PEAK 21(13Q14.2) WILD-TYPE 414 99 184 6

Figure S215.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_13q14.2' versus 'PATHOLOGY_N_STAGE'

P value = 0.015 (Fisher's exact test), Q value = 0.045

Table S216.  Gene #34: 'del_13q14.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 21(13Q14.2) MUTATED 69 14 4
DEL PEAK 21(13Q14.2) WILD-TYPE 248 29 2

Figure S216.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_13q14.2' versus 'GENDER'

P value = 0.0125 (Fisher's exact test), Q value = 0.039

Table S217.  Gene #34: 'del_13q14.2' versus Clinical Feature #7: 'GENDER'

nPatients FEMALE MALE
ALL 287 572
DEL PEAK 21(13Q14.2) MUTATED 63 85
DEL PEAK 21(13Q14.2) WILD-TYPE 224 487

Figure S217.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #7: 'GENDER'

'del_13q14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S218.  Gene #34: 'del_13q14.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 21(13Q14.2) MUTATED 43 82 23
DEL PEAK 21(13Q14.2) WILD-TYPE 23 442 246

Figure S218.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_13q14.2' versus 'RACE'

P value = 0.104 (Fisher's exact test), Q value = 0.21

Table S219.  Gene #34: 'del_13q14.2' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 21(13Q14.2) MUTATED 0 4 12 127
DEL PEAK 21(13Q14.2) WILD-TYPE 2 11 104 575

Figure S219.  Get High-res Image Gene #34: 'del_13q14.2' versus Clinical Feature #12: 'RACE'

'del_14q31.1' versus 'Time to Death'

P value = 8.67e-09 (logrank test), Q value = 8.8e-07

Table S220.  Gene #35: 'del_14q31.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 22(14Q31.1) MUTATED 273 103 0.1 - 129.4 (30.5)
DEL PEAK 22(14Q31.1) WILD-TYPE 570 108 0.1 - 194.8 (30.5)

Figure S220.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #1: 'Time to Death'

'del_14q31.1' versus 'YEARS_TO_BIRTH'

P value = 0.0799 (Wilcoxon-test), Q value = 0.18

Table S221.  Gene #35: 'del_14q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 22(14Q31.1) MUTATED 273 61.3 (12.4)
DEL PEAK 22(14Q31.1) WILD-TYPE 580 59.6 (12.6)

Figure S221.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_14q31.1' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S222.  Gene #35: 'del_14q31.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 22(14Q31.1) MUTATED 103 31 83 54
DEL PEAK 22(14Q31.1) WILD-TYPE 345 72 107 46

Figure S222.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_14q31.1' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S223.  Gene #35: 'del_14q31.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 22(14Q31.1) MUTATED 110 40 119 5
DEL PEAK 22(14Q31.1) WILD-TYPE 352 83 132 10

Figure S223.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_14q31.1' versus 'PATHOLOGY_N_STAGE'

P value = 0.00205 (Fisher's exact test), Q value = 0.0083

Table S224.  Gene #35: 'del_14q31.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 22(14Q31.1) MUTATED 108 26 3
DEL PEAK 22(14Q31.1) WILD-TYPE 209 17 3

Figure S224.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_14q31.1' versus 'PATHOLOGY_M_STAGE'

P value = 4.84e-05 (Fisher's exact test), Q value = 0.00033

Table S225.  Gene #35: 'del_14q31.1' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 22(14Q31.1) MUTATED 185 51
DEL PEAK 22(14Q31.1) WILD-TYPE 357 38

Figure S225.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_14q31.1' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0447 (Wilcoxon-test), Q value = 0.11

Table S226.  Gene #35: 'del_14q31.1' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 22(14Q31.1) MUTATED 30 82.0 (29.3)
DEL PEAK 22(14Q31.1) WILD-TYPE 85 93.2 (9.5)

Figure S226.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_14q31.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S227.  Gene #35: 'del_14q31.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 22(14Q31.1) MUTATED 3 226 45
DEL PEAK 22(14Q31.1) WILD-TYPE 63 298 224

Figure S227.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_14q31.1' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.00272 (Wilcoxon-test), Q value = 0.011

Table S228.  Gene #35: 'del_14q31.1' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
DEL PEAK 22(14Q31.1) MUTATED 11 1987.4 (14.2)
DEL PEAK 22(14Q31.1) WILD-TYPE 56 1970.7 (15.5)

Figure S228.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'del_14q31.1' versus 'RACE'

P value = 0.011 (Fisher's exact test), Q value = 0.035

Table S229.  Gene #35: 'del_14q31.1' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 22(14Q31.1) MUTATED 0 3 24 240
DEL PEAK 22(14Q31.1) WILD-TYPE 2 12 92 462

Figure S229.  Get High-res Image Gene #35: 'del_14q31.1' versus Clinical Feature #12: 'RACE'

'del_16q23.3' versus 'Time to Death'

P value = 9.39e-06 (logrank test), Q value = 7.6e-05

Table S230.  Gene #36: 'del_16q23.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 23(16Q23.3) MUTATED 35 18 0.1 - 90.5 (27.6)
DEL PEAK 23(16Q23.3) WILD-TYPE 808 193 0.1 - 194.8 (30.6)

Figure S230.  Get High-res Image Gene #36: 'del_16q23.3' versus Clinical Feature #1: 'Time to Death'

'del_16q23.3' versus 'NEOPLASM_DISEASESTAGE'

P value = 0.00647 (Fisher's exact test), Q value = 0.022

Table S231.  Gene #36: 'del_16q23.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 23(16Q23.3) MUTATED 11 4 11 10
DEL PEAK 23(16Q23.3) WILD-TYPE 437 99 179 90

Figure S231.  Get High-res Image Gene #36: 'del_16q23.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_16q23.3' versus 'PATHOLOGY_T_STAGE'

P value = 0.00014 (Fisher's exact test), Q value = 0.00081

Table S232.  Gene #36: 'del_16q23.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 23(16Q23.3) MUTATED 12 4 15 5
DEL PEAK 23(16Q23.3) WILD-TYPE 450 119 236 10

Figure S232.  Get High-res Image Gene #36: 'del_16q23.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_16q23.3' versus 'PATHOLOGY_N_STAGE'

P value = 0.00046 (Fisher's exact test), Q value = 0.0023

Table S233.  Gene #36: 'del_16q23.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 23(16Q23.3) MUTATED 12 7 2
DEL PEAK 23(16Q23.3) WILD-TYPE 305 36 4

Figure S233.  Get High-res Image Gene #36: 'del_16q23.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_18q22.2' versus 'Time to Death'

P value = 6.48e-07 (logrank test), Q value = 5.5e-05

Table S234.  Gene #37: 'del_18q22.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 24(18Q22.2) MUTATED 149 59 0.1 - 123.6 (25.6)
DEL PEAK 24(18Q22.2) WILD-TYPE 694 152 0.1 - 194.8 (31.3)

Figure S234.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #1: 'Time to Death'

'del_18q22.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S235.  Gene #37: 'del_18q22.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 24(18Q22.2) MUTATED 51 12 55 31
DEL PEAK 24(18Q22.2) WILD-TYPE 397 91 135 69

Figure S235.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_18q22.2' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S236.  Gene #37: 'del_18q22.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 24(18Q22.2) MUTATED 54 17 73 7
DEL PEAK 24(18Q22.2) WILD-TYPE 408 106 178 8

Figure S236.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_18q22.2' versus 'PATHOLOGY_N_STAGE'

P value = 0.0213 (Fisher's exact test), Q value = 0.06

Table S237.  Gene #37: 'del_18q22.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 24(18Q22.2) MUTATED 64 15 3
DEL PEAK 24(18Q22.2) WILD-TYPE 253 28 3

Figure S237.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_18q22.2' versus 'PATHOLOGY_M_STAGE'

P value = 0.00917 (Fisher's exact test), Q value = 0.029

Table S238.  Gene #37: 'del_18q22.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 24(18Q22.2) MUTATED 97 27
DEL PEAK 24(18Q22.2) WILD-TYPE 445 62

Figure S238.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_18q22.2' versus 'YEAR_OF_TOBACCO_SMOKING_ONSET'

P value = 0.117 (Wilcoxon-test), Q value = 0.24

Table S239.  Gene #37: 'del_18q22.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

nPatients Mean (Std.Dev)
ALL 67 1973.4 (16.4)
DEL PEAK 24(18Q22.2) MUTATED 8 1981.1 (13.2)
DEL PEAK 24(18Q22.2) WILD-TYPE 59 1972.4 (16.6)

Figure S239.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #11: 'YEAR_OF_TOBACCO_SMOKING_ONSET'

'del_18q22.2' versus 'RACE'

P value = 0.0746 (Fisher's exact test), Q value = 0.17

Table S240.  Gene #37: 'del_18q22.2' versus Clinical Feature #12: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN WHITE
ALL 2 15 116 702
DEL PEAK 24(18Q22.2) MUTATED 0 6 15 128
DEL PEAK 24(18Q22.2) WILD-TYPE 2 9 101 574

Figure S240.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #12: 'RACE'

'del_18q22.2' versus 'ETHNICITY'

P value = 0.0894 (Fisher's exact test), Q value = 0.19

Table S241.  Gene #37: 'del_18q22.2' versus Clinical Feature #13: 'ETHNICITY'

nPatients HISPANIC OR LATINO NOT HISPANIC OR LATINO
ALL 42 597
DEL PEAK 24(18Q22.2) MUTATED 3 106
DEL PEAK 24(18Q22.2) WILD-TYPE 39 491

Figure S241.  Get High-res Image Gene #37: 'del_18q22.2' versus Clinical Feature #13: 'ETHNICITY'

'del_19p13.3' versus 'Time to Death'

P value = 8.5e-12 (logrank test), Q value = 2.2e-09

Table S242.  Gene #38: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 843 211 0.1 - 194.8 (30.5)
DEL PEAK 25(19P13.3) MUTATED 40 21 0.1 - 109.9 (17.5)
DEL PEAK 25(19P13.3) WILD-TYPE 803 190 0.1 - 194.8 (31.3)

Figure S242.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

'del_19p13.3' versus 'NEOPLASM_DISEASESTAGE'

P value = 6e-05 (Fisher's exact test), Q value = 0.00038

Table S243.  Gene #38: 'del_19p13.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 25(19P13.3) MUTATED 10 1 17 11
DEL PEAK 25(19P13.3) WILD-TYPE 438 102 173 89

Figure S243.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_19p13.3' versus 'PATHOLOGY_T_STAGE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S244.  Gene #38: 'del_19p13.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 25(19P13.3) MUTATED 11 2 23 4
DEL PEAK 25(19P13.3) WILD-TYPE 451 121 228 11

Figure S244.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_19p13.3' versus 'PATHOLOGY_N_STAGE'

P value = 0.00022 (Fisher's exact test), Q value = 0.0012

Table S245.  Gene #38: 'del_19p13.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 25(19P13.3) MUTATED 10 7 2
DEL PEAK 25(19P13.3) WILD-TYPE 307 36 4

Figure S245.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_19p13.3' versus 'PATHOLOGY_M_STAGE'

P value = 0.064 (Fisher's exact test), Q value = 0.15

Table S246.  Gene #38: 'del_19p13.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

nPatients 0 1
ALL 542 89
DEL PEAK 25(19P13.3) MUTATED 17 7
DEL PEAK 25(19P13.3) WILD-TYPE 525 82

Figure S246.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #6: 'PATHOLOGY_M_STAGE'

'del_19p13.3' versus 'KARNOFSKY_PERFORMANCE_SCORE'

P value = 0.0779 (Wilcoxon-test), Q value = 0.17

Table S247.  Gene #38: 'del_19p13.3' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

nPatients Mean (Std.Dev)
ALL 115 90.3 (17.6)
DEL PEAK 25(19P13.3) MUTATED 9 80.0 (30.8)
DEL PEAK 25(19P13.3) WILD-TYPE 106 91.1 (15.9)

Figure S247.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #8: 'KARNOFSKY_PERFORMANCE_SCORE'

'del_19p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.0287 (Fisher's exact test), Q value = 0.076

Table S248.  Gene #38: 'del_19p13.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 25(19P13.3) MUTATED 3 17 20
DEL PEAK 25(19P13.3) WILD-TYPE 63 507 249

Figure S248.  Get High-res Image Gene #38: 'del_19p13.3' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

'del_xp22.2' versus 'YEARS_TO_BIRTH'

P value = 0.00136 (Wilcoxon-test), Q value = 0.006

Table S249.  Gene #39: 'del_xp22.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

nPatients Mean (Std.Dev)
ALL 853 60.1 (12.6)
DEL PEAK 26(XP22.2) MUTATED 123 56.2 (13.9)
DEL PEAK 26(XP22.2) WILD-TYPE 730 60.8 (12.2)

Figure S249.  Get High-res Image Gene #39: 'del_xp22.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_xp22.2' versus 'NEOPLASM_DISEASESTAGE'

P value = 1e-04 (Fisher's exact test), Q value = 0.00061

Table S250.  Gene #39: 'del_xp22.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

nPatients STAGE I STAGE II STAGE III STAGE IV
ALL 448 103 190 100
DEL PEAK 26(XP22.2) MUTATED 43 24 39 14
DEL PEAK 26(XP22.2) WILD-TYPE 405 79 151 86

Figure S250.  Get High-res Image Gene #39: 'del_xp22.2' versus Clinical Feature #3: 'NEOPLASM_DISEASESTAGE'

'del_xp22.2' versus 'PATHOLOGY_T_STAGE'

P value = 0.00025 (Fisher's exact test), Q value = 0.0013

Table S251.  Gene #39: 'del_xp22.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

nPatients T1 T2 T3 T4
ALL 462 123 251 15
DEL PEAK 26(XP22.2) MUTATED 44 26 49 3
DEL PEAK 26(XP22.2) WILD-TYPE 418 97 202 12

Figure S251.  Get High-res Image Gene #39: 'del_xp22.2' versus Clinical Feature #4: 'PATHOLOGY_T_STAGE'

'del_xp22.2' versus 'PATHOLOGY_N_STAGE'

P value = 0.0948 (Fisher's exact test), Q value = 0.2

Table S252.  Gene #39: 'del_xp22.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

nPatients N0 N1 N2
ALL 317 43 6
DEL PEAK 26(XP22.2) MUTATED 48 11 2
DEL PEAK 26(XP22.2) WILD-TYPE 269 32 4

Figure S252.  Get High-res Image Gene #39: 'del_xp22.2' versus Clinical Feature #5: 'PATHOLOGY_N_STAGE'

'del_xp22.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05

Table S253.  Gene #39: 'del_xp22.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

nPatients KIDNEY CHROMOPHOBE KIDNEY CLEAR CELL RENAL CARCINOMA KIDNEY PAPILLARY RENAL CELL CARCINOMA
ALL 66 524 269
DEL PEAK 26(XP22.2) MUTATED 39 55 29
DEL PEAK 26(XP22.2) WILD-TYPE 27 469 240

Figure S253.  Get High-res Image Gene #39: 'del_xp22.2' versus Clinical Feature #9: 'HISTOLOGICAL_TYPE'

Methods & Data
Input
  • Copy number data file = all_lesions.txt from GISTIC pipeline

  • Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/KIPAN-TP/15087107/transformed.cor.cli.txt

  • Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/KIPAN-TP/15081103/KIPAN-TP.merged_data.txt

  • Number of patients = 859

  • Number of significantly focal cnvs = 39

  • Number of selected clinical features = 13

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)